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ABSTRACT 
Indocyanine green (ICG) fluorescence imaging is a surgical tool with increasing 
applications in colorectal surgery. This tool has received acceptance in various surgical 
disciplines as a potential method to enhance surgical field visualization, improve lymph 
node retrieval, and decrease anastomotic leaks. In colorectal surgery specifically, small 
studies have shown intraoperative fluorescence imaging is a safe and feasible method to 
assess anastomotic perfusion, and its use may impact anastomotic leak rates. Controlled 
trials are underway to validate these conclusions. In the meantime, new indications for 
ICG continue to develop, including innovative options for detecting and guiding 
management of colorectal metastasis to the liver. These advances could offer great value 
for surgeons and patients, by improving the accuracy and outcomes of oncologic 
resections. The purpose of this article is to review the literature on the current state of 
immunofluorescence in colon and rectal surgery and emerging applications. 
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Introduction  to Fluorescence Imaging 
Fluorescence imaging (FI) is emerging as a major contributor to intraoperative 
decision making during surgical procedures. With FI, the tissue of interest is 
illuminated with light at an excitation wavelength (750 -800 nm) while observing it 
emit fluorescence at longer emission wavelengths (over 800 nm) (1). Indocyanine 
green (ICG) is the fluorophore most commonly used in fluorescence imaging. ICG is 
a water-soluble, tricarbocyanine dye that binds to blood lipoproteins after 
intravenous injection and remains confined in the intravascular compartment until 
elimination. It is selectively taken up at the first pass by hepatocytes and excreted 
unchanged into the bile. This fluorophore has tissue penetration up to 5mm, a 
plasma half-life of 3–5 min, with biliary excretion in 15–20 min, making it ideal for 
repeated applications (2). ICG has been used in other clinical applications, such as 
determining cardiac output, hepatic function, liver blood flow, and ophthalmic 
angiography for several decades (1, 3, 4). Fluorescence imaging with the application 
of ICG is an area of new development, and the uses continue to grow in colorectal 
surgery. The long-standing safety and efficacy of ICG greatly facilitates its 
introduction to new applications in this field (1). To date, the most publicized 
application in colorectal surgery has been as fluorescence angiography for perfusion 
analysis of the colorectal anastomosis (5). However, the indications continue to 
expand, and these advances could offer great value for surgeons and patients, by 
improving the visualization, accuracy and outcomes of colorectal resections. The 
purpose of this article is to review the literature on the current state of 
immunofluorescence in colon and rectal surgery and emerging applications. 
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Search strategy and selection criteria 
For this narrative review, a team of surgeons that are subject matter experts in 
fluorescence angiography for gastrointestinal and hepatic surgery met to determine 
the clinically relevant areas and applications of fluorescence imaging with ICG in 
colorectal surgery. The consensus was: review of the available equipment, 
fluorescence angiography for anastomotic assessment, ureter visualization, 
endoscopic tattooing of colorectal lesions, lymphatic and sentinel lymph node 
mapping, and colorectal liver metastasis. Within each defined area, searches using 
the PubMed and Medline electronic databases were performed from database 
inception to May 2017 for original articles on the use if ICG in the setting of clinical 
studies in colorectal surgery. The following search terms were used: “fluorescence 
imaging”, “fluorescence angiography”, “Indocyanine green”, and “ICG” with 
“colorectal”, “colorectal surgery”, “perfusion”, “lymph node”, “sentinel lymph 
node”, “colorectal cancer”, “anastomotic leak”, “ureter” “hepatocellular cancer”, 
and “liver metastasis”, and “fluorophores” AND “imaging” AND “surgery”. 
Reference lists and specific authors who the team recognized as other subject matter 
experts in the field were also hand searched. Articles were included if published in 
English and full text was available. Conference proceedings and videos were not 
included. Abstracts were initially independently reviewed by 1 author (DK) for 
relevance to the defined sections and novelty. Then, full text for the selected articles 
was reviewed by all authors, minus the section on metastatic liver lesions, which was 
performed by TI. The content was written in a narrative format for full breadth of 
the details on the technical aspects, current state, and future application of the field. 
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Fluorescence Angiography: The Technical Details 
There are a few options for fluorescent angiography systems for laparoscopic and open 
surgery, including the Stryker 1588 AIM Platform (Portage, Michigan, USA), 
PINPOINT
TM 
(Novadaq, Mississauga, Ontario, Canada), the D-Light NIR/ICG
TM 
(Karl 
Storz, Tuttlingen, Germany), IC-View® (Pulsion Medical Systems, Munich, Germany), 
PDE-neo System
TM
 (Hamamatsu Photonics K.K., Hamamatsu, Japan), the SPY Elite™ 
Kit (LifeCell Corporation, Bridgewater, New Jersey, USA), and da Vinci robotic system- 
Firefly
TM
 (Intuitive Surgical Inc., Sunnyvale, California, USA). These systems function 
as a conventional laparoscope in white light mode, but can be activated into NIR mode, 
where the ICG is visualized as white fluorescence on a black background. The Novadaq 
system offers an additional PINPOINT dual display mode, where the green fluorescence 
is superimposed over the white-light image, providing a highlighted view of the tissue of 
interest (6). Surgeons should understand that the signal detectability in fluorescence 
imaging differs greatly among laparoscopic imaging systems and, in general, is inferior to 
open imaging systems (7). Studies have demonstrated the feasibility and safety of 
intraoperative fluorescence angiography using these systems, with no adverse effects 
related to the infusion of ICG (2, 5, 8–18). 
 
Fluorescence Angiography to Assess Anastomotic Perfusion 
Anastomotic leaks are a dreaded complication in gastrointestinal surgery. Despite 
technical advances in colorectal surgery, the rate of anastomotic leaks has been steady, 
reported in 3%-20% of colorectal cases (19, 20). The etiology of anastomotic leaks is 
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multifactorial, and their impact is widespread- adding a significant clinical and economic 
burden to the patient and healthcare system, as well as a predisposition to local cancer 
recurrence (20–26). The current diagnostic tests- including intraoperative endoscopic 
assessment, air leak testing, assessment of anastomotic donuts, measurement of local 
tissue oxygenation, CT scan, and water-soluble contrast enema - often fail to establish 
an anastomotic leak at stage early enough to allow timely intervention and minimize 
morbidity and mortality (24). And while a proximal diverting stoma can minimize the 
consequences of a leak, it does not reduce the risk (27). Thus, further study and new 
technology are warranted to address the issue of anastomotic leaks.   
 
Perfusion is vital for healing, and inadequate blood flow can result in failure of 
anastomotic healing and leak (28). Adequate perfusion of the anastomosis is commonly 
confirmed by assessing palpable pulses in the mesentery, lack of bowel discoloration, and 
pulsatile bleeding from its cut ends; however, this method of assessment can be 
subjective and difficult to quantify.  
 
A valuable tool to visualize perfusion of the bowel anastomosis is fluorescence 
angiography. Fluorescence angiography can help confirm anastomotic perfusion by 
visualizing the bowel perfusion intraoperatively in real-time. For detection of blood 
flow, 2–3 mL of ICG solution (2.5 mg/mL) is injected intravenously during the 
operation by the anesthetist. After intravenous injection, ICG is visualized as green 
when excited by light in the near-infrared (NIR) spectrum with a NIR camera in 30-
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60 seconds (29). This assessment allows the surgeon to confirm or revise a proposed 
resection margin after ligation of the vascular pedicle and before the anastomosis is 
created (5, 8). This interrogation of perfusion before the anastomosis is especially 
relevant in non-anatomic resections, where aberrant or altered vascular anatomy can 
impair perfusion to the remaining colon (FIGURE 1). In addition, the surgeon can verify 
perfusion of the completed anastomosis with an endoscopic mucosal angiography 
evaluation of the join (9).  
 
There is a growing body of literature supporting intraoperative assessment of perfusion 
impacting intraoperative management and patient outcomes, including anastomotic leak 
rate in colorectal surgery. Many studies evaluating immunofluorescence in colorectal 
anastomosis are retrospective case series in both laparoscopic and robotic colorectal 
resections (2, 5, 8, 10–18). These studies describe the technique as simple, taking 
approximately 5 minutes to perform whether laparoscopic or robotic (2, 18), and 
providing useful intraoperative information about the vascular perfusion during 
minimally invasive colorectal surgery, with promise to reduce anastomotic leak rates. 
Boni et al reported results of 107 laparoscopic colorectal resections (40 right colectomies, 
10 splenic flexure segmental resections, 35 left colectomies, and 22 anterior resections), 
where fluorescence demonstrated an insufficiently perfused bowel margin in 4/107 
patients, which was revised before anastomosis; none of these patients had a clinical leak 
(10). Gröne et al reported outcomes for consecutive rectal cancer patients who underwent 
laparoscopic anterior and lower anterior resection with fluorescence angiography over a 
5-months period, finding perfusion imaging influenced surgical decision making in 28% 
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of the patients; there was 1 anastomotic leak (6%, coloanal anastomosis) in all patients 
during that period (11). Hellan et al. reported the outcome of perfusion assessment in 40 
patients having robotic left-sided colon or rectal resection, where angiography led to a 
change in the proposed transection line in 40% of cases; anastomotic leak occurred in 2 
patients whose site of transection had been revised (days 15 and 40) (18).  Jafari et al 
evaluated 16 robotic low anterior resections with ICG perfusion, where the use of 
fluorescence angiography resulted in revision of the proximal transection point before 
formation of the anastomosis in 19% of patients; only 1 anastomotic leak occurred in the 
fluorescence angiography group compared to 4 in a matched control group (8). Ris et al 
reported outcomes in 30 consecutive elective minimally invasive colorectal resections (24 
left-sided and 6 right-sided resections), where in addition to achieving no postoperative 
anastomotic leaks, the authors reported that visualizing the perfusion also encouraged 
avoidance of defunctioning stomas in three patients with low anastomoses (2). 
 
With increasing utilization of the tool, the quality and volume of the evidence for 
fluorescence angiography in anastomotic assessment continues to grow. Boni et al 
completed a case-matched study, comparing 42 fluorescent angiography patients to 38 
historic controls undergoing laparoscopic low anterior resection. From fluorescent 
angiography-demonstrated hypoperfusion, the planned anastomotic level was revised in 
4.7 %. There were 2 anastomotic leaks in the control group, and none in the fluorescent 
angiography group (30). While the sample size is too small to power conclusions, they 
felt it could lead to a reduction in the anastomotic leakage after total mesorectal 
excisions. Kudszus et al performed a case-matched study in 402 colorectal cancer 
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patients, with a subgroup analysis by elective/ emergent case status and age, for the rate 
of anastomotic revision for leakage. They found an overall reduction in the absolute 
revision rate of the anastomosis of 4% in with fluorescence angiography, with 
significantly reduced rate of revision in the subgroup analysis of patients undergoing 
elective resections (3.1% vs. 7.7%, p = 0.04, risk of revision reduced by 60%) and in 
patients older than 70 years (4.3% vs. 11.9%; p = 0.04, risk of revision reduced by 64%), 
supporting that ICG fluorescence may significantly reduce the rate of severe 
complications in colorectal surgery (31). Kin et al also performed a case-matched study 
in colectomy and proctectomy patient, but concluded that the technology was not 
associated with a reduced colorectal anastomotic leak (32). Five percent of patients in the 
fluorescent angiography group had a revision of the planned resection margin. In the 173 
pairs, they found 7.5% of the fluorescent angiography group developed an anastomotic 
leak versus 6.4% of controls. Multivariate analysis demonstrated that level of 
anastomosis and surgeon was associated with leaks (32). There were several issues 
with this study’s design that could account for the divergent results found in this 
work compared to other studies. The study was retrospective, with a historic control 
group used for matching. There was also a small overall sample size, and even 
smaller number of anastomotic leaks, (n=24), resulting in an underpowered 
analysis. With the lack of controlled studies and conflicting data, additional studies are 
necessary to determine whether this technology is beneficial for colorectal surgery. A 
recent systematic review of 10 cohort studies (916 patient) reported that intraoperative 
fluorescent angiography was associated with a reduced risk of anastomotic leakage 
(n = 23/693; 3.3 % (95 % CI 1.97-4.63 %) compared with no fluorescent angiography 
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assessment (n = 19/223; 8.5 %; 95 % CI 4.8-12.2 %) (33). In the PILLAR-II 
prospective, multicenter, open-label, clinical trial performed at 11 centers across the 
United States, 139 patients undergoing left-sided colectomy and anterior resection 
had perfusion assessment (5). Fluorescence angiography changed the operative plan 
in 8% of patients (n=11). The overall anastomotic leak rate was 1.4%, and there 
were no anastomotic leaks in the 11 patients who had a change in operative plan. 
While the existing body of literature is promising, we await randomized data to 
define the role for fluorescence angiography in routine clinical practice. The 
PILLAR III multi-center randomized controlled trial is currently underway, and we 
anxiously await the results (ClinicalTrials.gov identifier: NCT02205307) (34). 
 
One limitation that deserves mention in the currently available NIR imaging systems is 
the subjective evaluation of fluorescence intensity and lack of quantitative data to 
measure tissue perfusion- leaving surgeons with the question, “How green is green?” 
Nerup et al aimed to establish a method to quantify perfusion in ICG fluorescence 
angiography in an animal model. After marking regions of interest in the stomach, 
the authors administered ICG and neutron-activated microspheres, performed NIR 
fluorescence, and then sampled the marked tissue to calculate the regional blood 
flow (35). They found a strong correlation between regional blood flow and the slope 
of the fluorescence curves, with acceptable correlation to predictive algorithms they 
developed. While the models show quantification of perfusion is feasible, the clinical 
applications of this theoretical work in animal models is pending (35). In 2 separate 
single-institution studies in human subjects, the absolute perfusion units were reported 
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as a recommendation of when to resect; the threshold value for absolute perfusion units in 
these reports were 18-20 (14, 36). Wada et al aimed to quantify assessment of intestinal 
perfusion by reviewing recorded video images and creating a time–fluorescence intensity 
curve at the point of bowel transection (37). They found that the fluorescence difference 
between maximum and baseline was the most indicative factor for anastomotic leak, with 
a sensitivity of 100% and a specificity of 92.5%. Further, no correlation between 
anastomotic leak and the time from ICG injection to the first visible fluorescence signal 
was found (37). While these studies are promising, controlled trials with larger sample 
sizes are needed to standardize and validate the quantitative models.  In the meantime, the 
adequacy of anastomotic perfusion remains subjective.  
 
 
Emerging Uses of Fluorescence Angiography in Colorectal Surgery  
While developed to assess perfusion, various other uses of fluorescence angiography are 
being reported, which compliment the standard of care in colorectal surgery, and could 
facilitate improving patient outcomes. 
Ureter Visualization 
Iatrogenic ureteral injury is a relatively rare but devastating complication in colorectal 
surgery, with significant morbidity (38, 39). While rare overall, a higher incidence is 
reported with laparoscopic colorectal surgery, especially in rectal cancer resections (40, 
41). Preoperative ureteral stenting is an option, but it has not been shown to decrease the 
risk of ureteral injury- only helping with early identification of ureteral injuries (42). In 
addition, there are complications and costs associated with placing stents, including 
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increased operative time and an increase in length of stay (42, 43). ICG fluorescence of 
the ureters has value for facilitating ureter identification, especially in minimally invasive 
colorectal surgery (FIGURE 2). The ICG binds proteins on urothelial layer on the ureter, 
reversibly staining the inner lining of the ureter, and allowing visualization of the green-
illuminated ureter under NIR fluorescence (44). As ICG fluorescence penetrates tissue, 
the intraureteral ICG may be used to localize the entire course of the ureters, even when 
obscured in fibrotic tissue. While the intraureteral ICG cannot detect thermal or 
devascularization injuries, full-thickness ureteral injuries can be identified cause readily 
apparent leakage of ICG into the surgical field (FIGURE 3). Studies have described the 
technique, feasibility, and utility for visual identification of the ureters during 
laparoscopic (45–47) and robotic surgery using the Firefly® system (44, 48–50). The 
protocols described between 0.125-1mg/kg of methylene blue (45, 47) and 10-25mg of 
ICG dissolved in 10-mL of sterile water and injected through the open catheter, either as 
a bolus or through slow infusion over 5 minutes (44, 48–50).  Maximum fluorescence 
was reported between 9 and 20 minutes from administration (45). The reported results 
describe bilateral ureters fluorescing green in 50-91% when methylene blue was 
used, and 100% of patients with ICG (44, 45, 47–50). The fluorescence persisted 
through the duration of the operative procedure (mean operative times 121- 171.3 
minutes), despite some variation in brightness from the depth of the ureter to the 
peritoneal surface across patients (44, 48–50). No intraoperative or postoperative 
adverse effects attributable to fluorophore administration were reported (44, 47–
49). Further study will determine the role for this useful adjunct to prevent iatrogenic 
ureteral injury during pelvic dissection in colorectal surgery. 
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Endoscopic Tattooing Of Colorectal Lesions 
Preoperative endoscopic tattooing of colorectal neoplasms facilitates localization at the 
time of surgery, and is crucial for appropriate resection and treatment planning (51). 
Tattooing has become especially important in the era of minimally invasive surgery, with 
the lack of tactile feedback afforded during resection (52). The correct measurement and 
appropriate margins facilitated by precise localization could directly impact recurrence 
and survival. India ink has been the standard marking agent, but complications have been 
reported, including perforation, peritonitis, abscesses, inflammatory pseudotumors, and 
adhesion-related ileus (53–55). ICG has been reported as the endoscopic tattoo agent in 
several studies to guide colorectal resections (56–61). In these reports, peritumoral 
injection before open or minimally invasive resection using NIR fluorescence to identify 
the lesion has been reported to be safe, feasible, and effective. No adverse effects have 
been reported and all colorectal lesions were visualized upon open or laparoscopic 
resection. The median time for injection of ICG has been reported as 4 days prior to 
resection, but the ICG has been described as visible up to 7 days after endoscopic 
injection; after 9-10 days, the agent was visible in only 20% of patients (58, 60). A 
comparative study was performed by Nagata et al, who endoscopically injected 24 
patients with both ICG and India ink injected at separate sites within 4 days of 
laparoscopic colorectal surgery (59). They found the NIR fluorescence showed tumor 
location clearly and accurately in 100% of patients, while 10 of 24 patients had negative 
staining of India ink. The site of ICG injection did not reveal fibrosis, inflammation, 
necrosis or microabscesses, while the India Ink injection sites had vasculitis, necrosis, 
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edema, and neutrophilic infiltration of the bowel wall. While large scale, controlled trails 
are needed to define the site, concentration, and timing, from the benefits reported, ICG 
has value as a preoperative marking agent to identify tumor location. 
Lymphatic Mapping and Sentinel Lymph Node Identification 
In oncologic resections, sentinel lymph node mapping allows targeted identification and 
harvesting of potentially metastatic lymph nodes (62). Taking a clue from breast and 
gynecologic malignancies (63, 64), ICG is emerging as a powerful tool for lymphatic 
mapping, identification of micrometastatic disease, and focused target nodal assessment 
in colorectal cancer. There is the potential that the NIR information could change the 
operative course and recommendations for adjuvant therapy postoperatively. A few 
studies have reported the ICG immunofluorescence provided valuable information for 
finding lymph nodes; if these nodes are present outside of the traditional resection field, 
the operative strategy could be changed from this information (61, 65–68). It was noted 
that ICG may be may be less reliable due to neoadjuvant therapy in rectal cancers 
(61). Near-infrared fluorescence mapping of the pelvic side-wall in low rectal cancer can 
also guide the need for extended lymphadenectomy in appropriate patients, and spare 
patients with tumor-negative sentinel nodes from the morbidity of a lateral pelvic 
sidewall node dissection (67, 69). Intraoperative lymphatic mapping may also help 
define the lymphatic course for tumors that have variable drainage or in reoperative 
cases, where lymphatic-bearing tissue has been excised (56).  The sentinel lymph node 
biopsy could have specific utility in transanal resections of rectal cancer, where 
identification could change the treatment course to a more radical resection. Arezzo et al 
performed a submucosal ICG injection in 3 patients, then used NIR fluorescence to map 
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the mesorectal lymphatics and guide full-thickness resection with any involved lymph 
nodes (70). In all 3 patients, the pathologist confirmed presence of excised nodes, lack of 
metastasis, and the patients were spared radical surgery. Published studies have described 
the accuracy and benefit with this tool. Cahill et al used ICG with intraoperative 
fluorescence for real-time identification of the lymphatic drainage and sentinel mesocolic 
lymph nodes in 18 patients undergoing laparoscopic surgery for colorectal cancer (56). 
They found the fluorescence helped identify the sentinel nodes- whether within the 
specimen or outside of the standard resection field- prior to formal dissection, and was 
valid to guide their resection. In their series, four of 18 patients had mesocolic sentinel 
lymph nodes outside of the traditional resection field identified with ICG 
immunofluorescence.  Hirche et al evaluated 26 patients with colon cancer with ICG, 
then visualized their lymphatic mapping and sentinel lymph nodes with 
immunofluorescence, comparing results to the histopathology for clinical feasibility, 
detection rate, and sensitivity (66). The found the ICG could have improved accuracy 
over conventional methods. Fluorescence imaging identified the sentinel lymph node in 
25/ 26 patients (detection rate, 96%); metastatic involvement was found in 9/11 nodal 
positive patients by conventional histopathology, a sensitivity of 82% (66). To date, the 
rate of lymph node detection has been described from 89% to 98%, with a false negative 
rate of 18-67% (71). Nishigori et al reported in 21 patients undergoing laparoscopic 
resection for colorectal cancer with intraoperative immunofluorescence, the lymph node 
mapping demonstrated 23.5% of patients required modifications in the extent of 
lymphadenectomy and 16.7 % required a change in the plan of the intestinal resection 
(68). A recent systematic review and meta-analysis review was performed to 
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determine the overall sensitivity and specificity of ICG NIR fluorescence in sentinel 
lymph node detection in colorectal cancer. For 12 studies across 248 patients, the 
authors reported accuracy rate of 75.7% and pooled sensitivity and specificity rates 
of 71% and 84.6%, respectively (72). With further validation and accuracy, ICG 
immunofluorescence lymph node mapping could become a valuable tool to guide 
tailored, oncologic colorectal resections. However, further controlled trials are needed 
studies to determine the true impact and role on outcomes, especially in patients that have 
received neoadjuvant therapy. 
Detection of Colorectal Peritoneal Carcinomatosis  
In carcinomatosis with colorectal cancer, staging and the completeness of the 
cytoreductive surgery are important prognostic factors. (73) Fluorescence imaging 
may be a tool that facilitates intraoperative assessment of tumoral margins beyond 
the present methods of palpation and visual inspection (74). In a proof of concept 
study, Filippello et al showed ICG accumulation into the tumor mass of peritoneal 
carcinomatosis from colorectal cancer was due to the enhanced permeability and 
retention, which could be augmented with bevacizumab to inhibits neoangiogenesis 
(74). Barabino et al perfomed a pilot study of 10 patients to validate if ICG could to 
detect colorectal carcinomatosis in patients scheduled for cytoreductive surgery 
(73). After receiving 0.25 mg/kg of ICG intravenously 24 hours before surgery, 
42/58 cancerous lesions were correctly identified (72.4%). However, 12/30 non-
cancerous lesions were also identified, showing the test is sensitive but not specific. 
To improve the accuracy, Liberale et al looked at tumor-to-background ratios in 
suspected lesions in patients with peritoneal metastases from colorectal cancer 
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undergoing cytoreductive surgery. Patients received 0.25 mg/kg intravenous 
intraoperatively, then had a tumor-to-background ratio calculated for all resected 
lesions, finding a significant difference betweeb malignant and benign nodules. In 
29%, this information modified the surgical decision-making (75). While promising, 
further work is needed to improve the accuracy of this application. 
 
ICG to Guide Safe Transanal Total Mesorectal Excision (TaTME) 
A new procedure gaining popularity for TME dissection is to perform the procedure 
via a combined laparoscopic abdominal and transanal approach: transanal total 
mesorectal excision (TaTME) (76, 77). This new technique requires specific training 
and distinct pattern recognition from the abdominal approach (78). Consequently, 
there is potential to easily enter an incorrect plane, resulting in bleeding, autonomic 
nerve injury, and urethral injury – usually of the membranous portion from 
inadvertent mobilization of the prostate (79, 80). FI with ICG has been described to 
facilitate identifying the transanal TME dissection plane, which could potentially 
help avoid injuries, including to the urethra. Dapri et al demonstrated the 
intraluminal dissection plane NIR during a single TaTME case, helping to identify 
the presacral fascia and correct plane of dissection (81). In a cadaver proof of 
concept study, Barnes at al demonstrated the feasibility, with fluorescence to 
visualize the urethra specifically, demonstrating the urethra in eight of eight 
cadavers (82).  Further application of this tool and integration into TaTME training 
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models could improve the safety and complication profile for this new procedure, 
especially during the learning curve. 
 
ICG to Confirm Traditional Anatomic Perfusion Models 
ICG has also been used to verify blood flow (or lack thereof) in cases of ischemia, and to 
demonstrate the watershed areas and marginal arteries. Nowak et al used fluorescence 
angiography in 4 emergent cases of mesenteric ischemia, where recoverable, perfused 
regions of colon where visualized, and the length of bowel resected was significantly 
changed in 1 of the 4 cases (83). Watanabe et al used ICG to evaluate perfusion in 
patients who underwent left-sided and anterior resections with the blood flow through the 
last sigmoid arterial branch interrupted, leaving the rectosigmoid junction supplied by 
only the marginal artery (15). They found only 57.1% had a good anastomosis of the 
marginal artery near the rectosigmoid junction, with the remainder having either 
diminished, delayed or no fluorescence.  Ryu et al describe successful application of 
intraoperative ICG fluorescence angiography to confirm a reported watershed area in the 
Superior Rectal artery (84). With the new understanding of the mesentery as a continuous 
and contiguous structure with avascular areas between arterial trunks, this could provide 
useful information to guide precise anatomic resections (85, 86). In a single case, 
Atallah et al successfully used the technology for quantitative, real-time adequate 
perfusion assessment of an anorectal advancement flap (87). Future studies will no 
doubt expand on the use of fluorescence imaging to delineate anatomy and help 
guide appropriate resection. 
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Metastatic Colorectal Lesions to the Liver 
ICG fluorescence imaging has been used in the field of hepatobiliary surgery for 
intraoperative identification of the bile ducts and hepatic tumors for years before its 
application in colorectal perfusion assessment (88–90). ICG fluorescence imaging is 
emerging as a navigation tool for resecting metastatic hepatic tumors in 
laparoscopic hepatectomy. The tool may help surgeons safely and accurately 
identify colorectal metastatic lesions and complete laparoscopic hepatectomies, 
compensating for the limitations in tactile feedback and ultrasound intraoperative 
of the hepatic surfaces (91–94). The accumulation of ICG in metastatic liver tumors is 
associated with biliary excretion disorders, which can be caused by morphological 
obstruction in the biliary system and/or functional decrease in biliary transport, and 
result in accumulation of ICG in the cancerous tissues after preoperative 
intravenous administration (95–98) (FIGURE 4). While the tissue permeability of the 
fluorescence signal is limited to 5-8mm from the hepatic surfaces, the technique highly 
sensitive for detecting small and grossly unidentifiable metastatic lesions in real time, 
enhancing the accuracy of liver segmentation for resection and operative staging. (88, 99). 
The technical details regarding dose and timing of ICG administration have not yet been 
standardized for the intraoperative fluorescence imaging of metastatic hepatic tumors. In 
most cases, the ICG was administered for preoperative liver function test at a dose of 
0.25-0.5 mg/kg body weight between 1 day and 2 weeks before surgery (91, 100). Since 
ICG-fluorescence imaging of hepatic tumors is not a cancer-specific modality, the false 
positive rates in the present technique are relatively high (~40%) (99). With this high 
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false positive rate, lesions newly detected by ICG-fluorescence imaging should be 
confirmed by other modalities, such as palpation or intraoperative ultrasonography, 
before being resected. The false-positive rate can be reduced by not administering ICG on 
the day before surgery, especially in patients with decreased liver function from cirrhosis 
or preoperative chemotherapy. With the development of cancer-specific fluorophores, the 
specificity of intraoperative fluorescence to identify colorectal cancerous tissues can be 
improved, and could potentially become standard of care (101). 
 
CONCLUSIONS 
ICG fluorescence imaging is a valuable tool that aids decision-making and potentially 
improves outcomes in colorectal surgery. While initially introduced as an agent to assess 
anastomotic perfusion, the applications of fluorescence angiography continue to evolve. 
The current literature demonstrates the tool is safe, feasible, and beneficial in a broad 
array of colorectal-related procedures. As we await prospective randomized controlled 
trials to define the standards for utilization, the tool continues to have a significant 
clinical benefit in minimally invasive colorectal surgery. Future studies will need to 
address the fluorophores used in fluorescence imaging. Currently, there are only 
two clinically available NIR fluorophores that support image-guided surgery: ICG 
(described here) and methylene blue. However, neither provides optimum specificity 
and stability for targeted image guidance (102). Therefore, it is of paramount 
importance to develop targeted NIR fluorophores for unmet clinical needs. New 
fluorophores are in development that are water soluble, biocompatible, have 
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absorption and emission maxima within the desired NIR spectra, and improved 
fluorescence performance (103–105). Novel agents are currently being tested in 
animal models, and some are used as molecular endoscopically tools, providing an 
enhanced, visual picture of the mucosal and molecular targets (106, 107). 
Fluorophores could also be used to label antibodies and other biomarkers, 
repurposing a therapeutic agent into a diagnostic agent (108–114). Thus, developing 
fluorophores with the properties absent in the currently and may contribute 
towards the on-going expansion of NIR-fluorescence guidance in colorectal surgery. 
With this vast potential for expanded use, studies will need to define the cost-
effectiveness of fluorescence imaging in colorectal surgery. The cost of new 
technology can be prohibitive for resource-limited healthcare systems, limiting 
widespread application. While fluorescence imaging seems to have a cost benefit in 
reducing complications and guiding appropriate resections, studies on the true 
value, considering outcomes, costs, and the patient experience, are warranted. 
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FIGURE LEGEND 
Figure 1: Fluorescence Angiography to Assess Anastomotic Perfusion. Using ICG 
fluorescence angiography demonstrates a non-perfused segment in bowel that looked 
grossly healthy  
Figure 2: ICG infusion in the ureter  
Figure 3: ICG demonstrating a ureteral injury 
Figure 4: Identification of colorectal liver metastasis by ICG-fluorescence imaging during 
laparoscopic hepatectomy. a. Fluorescence imaging delineates small subcapsular hepatic 
metastasis located in segment 8 (right), which is unidentified by white-light color 
imaging (left) or intraoperative ultrasonography; b. Hepatic transection line is set using 
fusion-fluorescence imaging of the tumor, which enables superimposition of fluorescence 
signals on color images; c. The resected specimen is cut with the use of fluorescence 
imaging, and 3 mm-metastatic nodule appears on a cut surface of the specimen (left, 
arrow). The tumor shows rim-type fluorescence signals (right). 
 
 
 
 
  
 24 
REFERENCES 
1. Jarmo T. Alander IK, Aki Laakso, Tommi Pätilä, Thomas Spillmann,Valery V. 
Tuchin, Maarit Venermo, and Petri Välisuo. A Review of Indocyanine Green 
Fluorescent Imaging in Surgery. International Journal of Biomedical Imaging. 
2012;2012:26. 
2. Ris F, Hompes R, Cunningham C et al. Near-infrared (NIR) perfusion angiography 
in minimally invasive colorectal surgery. Surg Endosc. 2014;28:2221-2226. 
3. Owens SL. Indocyanine green angiography. Br J Ophthalmol. 1996;80:263-266. 
4. Levesque E, Martin E, Dudau D, Lim C, Dhonneur G, Azoulay D. Current use and 
perspective of indocyanine green clearance in liver diseases. Anaesth Crit Care Pain 
Med. 2016;35:49-57. 
5. Jafari MD, Wexner SD, Martz JE et al. Perfusion assessment in laparoscopic left-
sided/anterior resection (PILLAR II): a multi-institutional study. J Am Coll Surg. 
2015;220:82-92.e1. 
6. Fengler J. Near-infrared fluorescence laparoscopy--technical description of 
PINPOINT® a novel and commercially available system. Colorectal Dis. 2015;17 
Suppl 3:3-6. 
7. Kono Y, Ishizawa, T., Tani, K., Harada, N., Kaneko, J., Saiura, A., Bandai, Y., 
Kokudo, N. Techniques of fluorescence cholangiography during laparoscopic 
cholecystectomy for better delineation of the bile duct anatomy. Medicine. 
2015;94:1005. 
8. Jafari MD, Lee KH, Halabi WJ et al. The use of indocyanine green fluorescence to 
assess anastomotic perfusion during robotic assisted laparoscopic rectal surgery. 
Surg Endosc. 2013;27:3003-3008. 
9. Sherwinter DA. Transanal near-infrared imaging of colorectal anastomotic 
perfusion. Surg Laparosc Endosc Percutan Tech. 2012;22:433-436. 
10. Boni L, David G, Dionigi G, Rausei S, Cassinotti E, Fingerhut A. Indocyanine 
green-enhanced fluorescence to assess bowel perfusion during laparoscopic 
colorectal resection. Surg Endosc. 2016;30:2736-2742. 
11. Gröne J, Koch D, Kreis ME. Impact of intraoperative microperfusion assessment 
with Pinpoint Perfusion Imaging on surgical management of laparoscopic low rectal 
and anorectal anastomoses. Colorectal Dis. 2015;17 Suppl 3:22-28. 
12. Kawada K, Hasegawa S, Wada T et al. Evaluation of intestinal perfusion by ICG 
fluorescence imaging in laparoscopic colorectal surgery with DST anastomosis. 
Surg Endosc. 2017;31:1061-1069. 
13. Koh FH, Tan KK. Fluorescent Angiography Used to Evaluate the Perfusion Status 
of Anastomosis in Laparoscopic Anterior Resection. Ann Surg Oncol. 2016;23:692. 
14. Foppa C, Denoya PI, Tarta C, Bergamaschi R. Indocyanine green fluorescent dye 
during bowel surgery: are the blood supply “guessing days” over. Tech Coloproctol. 
2014;18:753-758. 
15. Watanabe J, Ota M, Suwa Y et al. Evaluation of the intestinal blood flow near the 
rectosigmoid junction using the indocyanine green fluorescence method in a 
colorectal cancer surgery. Int J Colorectal Dis. 2015;30:329-335. 
16. Bae SU, Min BS, Kim NK. Robotic Low Ligation of the Inferior Mesenteric Artery 
for Rectal Cancer Using the Firefly Technique. Yonsei Med J. 2015;56:1028-1035. 
 25 
17. Bae SU, Baek SJ, Hur H, Baik SH, Kim NK, Min BS. Intraoperative near infrared 
fluorescence imaging in robotic low anterior resection: three case reports. Yonsei 
Med J. 2013;54:1066-1069. 
18. Hellan M, Spinoglio G, Pigazzi A, Lagares-Garcia JA. The influence of 
fluorescence imaging on the location of bowel transection during robotic left-sided 
colorectal surgery. Surg Endosc. 2014;28:1695-1702. 
19. Vallance A, Wexner S, Berho M et al. A collaborative review of the current 
concepts and challenges of anastomotic leaks in colorectal surgery. Colorectal Dis. 
2017;19:O1-O12. 
20. Chadi SA, Fingerhut A, Berho M et al. Emerging Trends in the Etiology, 
Prevention, and Treatment of Gastrointestinal Anastomotic Leakage. J Gastrointest 
Surg. 2016;20:2035-2051. 
21. Choi HK, Law WL, Ho JW. Leakage after resection and intraperitoneal 
anastomosis for colorectal malignancy: analysis of risk factors. Dis Colon Rectum. 
2006;49:1719-1725. 
22. Hyman NH, Osler T, Cataldo P, Burns EH, Shackford SR. Anastomotic leaks after 
bowel resection: what does peer review teach us about the relationship to 
postoperative mortality. J Am Coll Surg. 2009;208:48-52. 
23. Alves A, Panis Y, Pocard M, Regimbeau JM, Valleur P. Management of 
anastomotic leakage after nondiverted large bowel resection. J Am Coll Surg. 
1999;189:554-559. 
24. Hirst NA, Tiernan JP, Millner PA, Jayne DG. Systematic review of methods to 
predict and detect anastomotic leakage in colorectal surgery. Colorectal Dis. 
2014;16:95-109. 
25. Hammond J, Lim S, Wan Y, Gao X, Patkar A. The burden of gastrointestinal 
anastomotic leaks: an evaluation of clinical and economic outcomes. J Gastrointest 
Surg. 2014;18:1176-1185. 
26. Goto S, Hasegawa S, Hida K et al. Multicenter analysis of impact of anastomotic 
leakage on long-term oncologic outcomes after curative resection of colon cancer. 
Surgery. 2017 
27. Alberts JC, Parvaiz A, Moran BJ. Predicting risk and diminishing the consequences 
of anastomotic dehiscence following rectal resection. Colorectal Dis. 2003;5:478-
482. 
28. Sheridan WG, Lowndes RH, Young HL. Tissue oxygen tension as a predictor of 
colonic anastomotic healing. Dis Colon Rectum. 1987;30:867-871. 
29. Cahill RA, Ris F, Mortensen NJ. Near-infrared laparoscopy for real-time intra-
operative arterial and lymphatic perfusion imaging. Colorectal Dis. 2011;13 Suppl 
7:12-17. 
30. Boni L, Fingerhut A, Marzorati A, Rausei S, Dionigi G, Cassinotti E. Indocyanine 
green fluorescence angiography during laparoscopic low anterior resection: results 
of a case-matched study. Surg Endosc. 2017;31:1836-1840. 
31. Kudszus S, Roesel C, Schachtrupp A, Höer JJ. Intraoperative laser fluorescence 
angiography in colorectal surgery: a noninvasive analysis to reduce the rate of 
anastomotic leakage. Langenbecks Arch Surg. 2010;395:1025-1030. 
32. Kin C, Vo H, Welton L, Welton M. Equivocal effect of intraoperative fluorescence 
angiography on colorectal anastomotic leaks. Dis Colon Rectum. 2015;58:582-587. 
 26 
33. Degett TH, Andersen HS, Gögenur I. Indocyanine green fluorescence angiography 
for intraoperative assessment of gastrointestinal anastomotic perfusion: a systematic 
review of clinical trials. Langenbecks Arch Surg. 2016;401:767-775. 
34. Clinicaltrials.gov. A Study Assessing Perfusion Outcomes With PINPOINT® 
Near Infrared Fluorescence Imaging in Low Anterior Resection (PILLAR III).  
35. Nerup N, Andersen HS, Ambrus R et al. Quantification of fluorescence 
angiography in a porcine model. Langenbecks Arch Surg. 2017;402:655-662. 
36. Protyniak B, Dinallo AM, Boyan WP, Dressner RM, Arvanitis ML. Intraoperative 
indocyanine green fluorescence angiography--an objective evaluation of 
anastomotic perfusion in colorectal surgery. Am Surg. 2015;81:580-584. 
37. Wada T, Kawada K, Takahashi R et al. ICG fluorescence imaging for quantitative 
evaluation of colonic perfusion in laparoscopic colorectal surgery. Surg Endosc. 
2017 
38. Bothwell WN, Bleicher RJ, Dent TL. Prophylactic ureteral catheterization in colon 
surgery. A five-year review. Dis Colon Rectum. 1994;37:330-334. 
39. Liguori G, Dobrinja C, Pavan N et al. Iatrogenic ureteral injury during laparoscopic 
colectomy: incidence and prevention A current literature review. Ann Ital Chir. 
2016;87:446-455. 
40. Marcelissen TA, Den Hollander PP, Tuytten TR, Sosef MN. Incidence of Iatrogenic 
Ureteral Injury During Open and Laparoscopic Colorectal Surgery: A Single Center 
Experience and Review of the Literature. Surg Laparosc Endosc Percutan Tech. 
2016;26:513-515. 
41. Andersen P, Andersen LM, Iversen LH. Iatrogenic ureteral injury in colorectal 
cancer surgery: a nationwide study comparing laparoscopic and open approaches. 
Surg Endosc. 2015;29:1406-1412. 
42. da Silva G, Boutros M, Wexner SD. Role of prophylactic ureteric stents in 
colorectal surgery. Asian J Endosc Surg. 2012;5:105-110. 
43. Speicher PJ, Goldsmith ZG, Nussbaum DP, Turley RS, Peterson AC, Mantyh CR. 
Ureteral stenting in laparoscopic colorectal surgery. J Surg Res. 2014;190:98-103. 
44. Siddighi S, Yune JJ, Hardesty J. Indocyanine green for intraoperative localization 
of ureter. Am J Obstet Gynecol. 2014;211:436.e1-2. 
45. Yeung TM, Volpi D, Tullis ID et al. Identifying Ureters In Situ Under Fluorescence 
During Laparoscopic and Open Colorectal Surgery. Ann Surg. 2016;263:e1-2. 
46. Korb ML, Huh WK, Boone JD et al. Laparoscopic Fluorescent Visualization of the 
Ureter With Intravenous IRDye800CW. J Minim Invasive Gynecol. 2015;22:799-
806. 
47. Al-Taher M, van den Bos J, Schols RM, Bouvy ND, Stassen LP. Fluorescence 
Ureteral Visualization in Human Laparoscopic Colorectal Surgery Using Methylene 
Blue. J Laparoendosc Adv Surg Tech A. 2016;26:870-875. 
48. Lee Z, Moore B, Giusto L, Eun DD. Use of indocyanine green during robot-assisted 
ureteral reconstructions. Eur Urol. 2015;67:291-298. 
49. Lee Z, Kaplan J, Giusto L, Eun D. Prevention of iatrogenic ureteral injuries during 
robotic gynecologic surgery: a review. Am J Obstet Gynecol. 2016;214:566-571. 
50. Park H, Farnam RW. Novel Use of Indocyanine Green for Intraoperative, Real-time 
Localization of Ureter During Robot-Assisted Excision of Endometriosis. J Minim 
Invasive Gynecol. 2015;22:S69. 
 27 
51. Acuna SA, Elmi M, Shah PS, Coburn NG, Quereshy FA. Preoperative localization 
of colorectal cancer: a systematic review and meta-analysis. Surg Endosc. 2016 
52. Feingold DL, Addona T, Forde KA et al. Safety and reliability of tattooing 
colorectal neoplasms prior to laparoscopic resection. J Gastrointest Surg. 
2004;8:543-546. 
53. Park SI, Genta RS, Romeo DP, Weesner RE. Colonic abscess and focal peritonitis 
secondary to india ink tattooing of the colon. Gastrointest Endosc. 1991;37:68-71. 
54. Coman E, Brandt LJ, Brenner S, Frank M, Sablay B, Bennett B. Fat necrosis and 
inflammatory pseudotumor due to endoscopic tattooing of the colon with india ink. 
Gastrointest Endosc. 1991;37:65-68. 
55. Gianom D, Hollinger A, Wirth HP. [Intestinal perforation after preoperative colonic 
tattooing with India ink]. Swiss Surg. 2003;9:307-310. 
56. Cahill RA, Anderson M, Wang LM, Lindsey I, Cunningham C, Mortensen NJ. 
Near-infrared (NIR) laparoscopy for intraoperative lymphatic road-mapping and 
sentinel node identification during definitive surgical resection of early-stage 
colorectal neoplasia. Surg Endosc. 2012;26:197-204. 
57. Hammond DC, Lane FR, Mackeigan JM, Passinault WJ. Endoscopic tattooing of 
the colon: clinical experience. Am Surg. 1993;59:205-210. 
58. Miyoshi N, Ohue M, Noura S et al. Surgical usefulness of indocyanine green as an 
alternative to India ink for endoscopic marking. Surg Endosc. 2009;23:347-351. 
59. Nagata J, Fukunaga Y, Akiyoshi T et al. Colonic Marking With Near-Infrared, 
Light-Emitting, Diode-Activated Indocyanine Green for Laparoscopic Colorectal 
Surgery. Dis Colon Rectum. 2016;59:e14-8. 
60. Watanabe M, Murakami M, Ozawa Y, Yoshizawa S, Matsui N, Aoki T. 
Intraoperative Identification of Colonic Tumor Sites Using a Near-Infrared 
Fluorescence Endoscopic Imaging System and Indocyanine Green. Dig Surg. 2017 
61. Handgraaf HJ, Boogerd LS, Verbeek FP et al. Intraoperative fluorescence imaging 
to localize tumors and sentinel lymph nodes in rectal cancer. Minim Invasive Ther 
Allied Technol. 2016;25:48-53. 
62. Daskalaki D, Aguilera F, Patton K, Giulianotti PC. Fluorescence in robotic surgery. 
J Surg Oncol. 2015;112:250-256. 
63. Jewell EL, Huang JJ, Abu-Rustum NR et al. Detection of sentinel lymph nodes in 
minimally invasive surgery using indocyanine green and near-infrared fluorescence 
imaging for uterine and cervical malignancies. Gynecol Oncol. 2014;133:274-277. 
64. Toh U, Iwakuma N, Mishima M, Okabe M, Nakagawa S, Akagi Y. Navigation 
surgery for intraoperative sentinel lymph node detection using Indocyanine green 
(ICG) fluorescence real-time imaging in breast cancer. Breast Cancer Res Treat. 
2015;153:337-344. 
65. Boni L, David G, Mangano A et al. Clinical applications of indocyanine green 
(ICG) enhanced fluorescence in laparoscopic surgery. Surg Endosc. 2015;29:2046-
2055. 
66. Hirche C, Mohr Z, Kneif S et al. Ultrastaging of colon cancer by sentinel node 
biopsy using fluorescence navigation with indocyanine green. Int J Colorectal Dis. 
2012;27:319-324. 
67. Kazanowski M, Al Furajii H, Cahill RA. Near-infrared laparoscopic fluorescence 
for pelvic side wall delta mapping in patients with rectal cancer--’PINPOINT’ nodal 
 28 
assessment. Colorectal Dis. 2015;17 Suppl 3:32-35. 
68. Nishigori N, Koyama F, Nakagawa T et al. Visualization of Lymph/Blood Flow in 
Laparoscopic Colorectal Cancer Surgery by ICG Fluorescence Imaging (Lap-IGFI). 
Ann Surg Oncol. 2016;23 Suppl 2:S266-74. 
69. Noura S, Ohue M, Seki Y et al. Feasibility of a lateral region sentinel node biopsy 
of lower rectal cancer guided by indocyanine green using a near-infrared camera 
system. Ann Surg Oncol. 2010;17:144-151. 
70. Arezzo A, Arolfo S, Mistrangelo M, Mussa B, Cassoni P, Morino M. Transrectal 
sentinel lymph node biopsy for early rectal cancer during transanal endoscopic 
microsurgery. Minim Invasive Ther Allied Technol. 2014;23:17-20. 
71. Marano A, Priora F, Lenti LM, Ravazzoni F, Quarati R, Spinoglio G. Application 
of fluorescence in robotic general surgery: review of the literature and state of the 
art. World J Surg. 2013;37:2800-2811. 
72. Emile SH, Elfeki H, Shalaby M et al. Sensitivity and specificity of indocyanine 
green near-infrared fluorescence imaging in detection of metastatic lymph nodes in 
colorectal cancer: Systematic review and meta-analysis. J Surg Oncol. 2017 
73. Barabino G, Klein JP, Porcheron J, Grichine A, Coll JL, Cottier M. Intraoperative 
Near-Infrared Fluorescence Imaging using indocyanine green in colorectal 
carcinomatosis surgery: Proof of concept. Eur J Surg Oncol. 2016;42:1931-1937. 
74. Filippello A, Porcheron J, Klein JP, Cottier M, Barabino G. Affinity of Indocyanine 
Green in the Detection of Colorectal Peritoneal Carcinomatosis. Surg Innov. 
2017;24:103-108. 
75. Liberale G, Vankerckhove S, Caldon MG et al. Fluorescence Imaging After 
Indocyanine Green Injection for Detection of Peritoneal Metastases in Patients 
Undergoing Cytoreductive Surgery for Peritoneal Carcinomatosis From Colorectal 
Cancer: A Pilot Study. Ann Surg. 2016;264:1110-1115. 
76. Lacy AM, Tasende MM, Delgado S et al. Transanal Total Mesorectal Excision for 
Rectal Cancer: Outcomes after 140 Patients. J Am Coll Surg. 2015;221:415-423. 
77. Arroyave MC, DeLacy FB, Lacy AM. Transanal total mesorectal excision 
(TaTME) for rectal cancer: Step by step description of the surgical technique for a 
two-teams approach. Eur J Surg Oncol. 2017;43:502-505. 
78. Bernardi MP, Bloemendaal AL, Albert M, Whiteford M, Stevenson AR, Hompes R. 
Transanal total mesorectal excision: dissection tips using ‘O’s and ‘triangles’. Tech 
Coloproctol. 2016;20:775-778. 
79. Penna M, Hompes R, Arnold S et al. Transanal Total Mesorectal Excision: 
International Registry Results of the First 720 Cases. Ann Surg. 2017;266:111-117. 
80. Atallah S, Mabardy A, Volpato AP, Chin T, Sneider J, Monson JRT. Surgery 
beyond the visible light spectrum: theoretical and applied methods for localization 
of the male urethra during transanal total mesorectal excision. Tech Coloproctol. 
2017 
81. Dapri G, Cahill R, Bourgeois P, Liberale G, Galdon Gomez M, Cadière GB. 
Peritumoural injection of indocyanine green fluorescence during transanal total 
mesorectal excision to identify the plane of dissection - a video vignette.[letter]. 
Colorectal Dis 2017;19(6):599-600. 
82. Barnes TG, Penna M, Hompes R, Cunningham C. Fluorescence to highlight the 
urethra: a human cadaveric study. Tech Coloproctol. 2017 
 29 
83. Nowak K, Sandra-Petrescu F, Post S, Horisberger K. Ischemic and injured bowel 
evaluation by Fluorescence imaging. Colorectal Dis. 2015;17 Suppl 3:12-15. 
84. Ryu S, Yoshida M, Hironori O et al. Intraoperative ICG fluorescence contrast 
imaging of the main artery watershed area in colorectal cancer surgery: Report of a 
case. Int J Surg Case Rep. 2016;26:176-178. 
85. Coffey JC, O’Leary DP. The mesentery: structure, function, and role in disease. 
Lancet Gastroenterol Hepatol. 2016;1:238-247. 
86. Sehgal R, Coffey JC. Historical development of mesenteric anatomy provides a 
universally applicable anatomic paradigm for complete/total mesocolic excision. 
Gastroenterol Rep (Oxf). 2014;2:245-250. 
87. Atallah SB, Albert MR, deBeche-Adams TC, Izfar S, Larach S. Application of 
laser-assisted indocyanine green fluorescent angiography for the assessment of 
tissue perfusion of anodermal advancement flaps. Dis Colon Rectum. 2013;56:797. 
88. Ishizawa T, Fukushima N, Shibahara J et al. Real-time identification of liver 
cancers by using indocyanine green fluorescent imaging. Cancer. 2009;115:2491-
2504. 
89. Ishizawa T, Bandai Y, Ijichi M, Kaneko J, Hasegawa K, Kokudo N. Fluorescent 
cholangiography illuminating the biliary tree during laparoscopic cholecystectomy. 
Br J Surg. 2010;97:1369-1377. 
90. Gotoh K, Yamada T, Ishikawa O et al. A novel image-guided surgery of 
hepatocellular carcinoma by indocyanine green fluorescence imaging navigation. J 
Surg Oncol. 2009;100:75-79. 
91. Terasawa M, Ishizawa T, Mise Y et al. Applications of fusion-fluorescence imaging 
using indocyanine green in laparoscopic hepatectomy. Surg Endosc. 2017 
92. Kudo H, Ishizawa T, Tani K et al. Visualization of subcapsular hepatic malignancy 
by indocyanine-green fluorescence imaging during laparoscopic hepatectomy. Surg 
Endosc. 2014;28:2504-2508. 
93. Uchiyama K, Ueno M, Ozawa S, Kiriyama S, Shigekawa Y, Yamaue H. Combined 
use of contrast-enhanced intraoperative ultrasonography and a fluorescence 
navigation system for identifying hepatic metastases. World J Surg. 2010;34:2953-
2959. 
94. Peloso A, Franchi E, Canepa MC et al. Combined use of intraoperative ultrasound 
and indocyanine green fluorescence imaging to detect liver metastases from 
colorectal cancer. HPB (Oxford). 2013;15:928-934. 
95. Ishizawa T, Masuda K, Urano Y et al. Mechanistic background and clinical 
applications of indocyanine green fluorescence imaging of hepatocellular 
carcinoma. Ann Surg Oncol. 2014;21:440-448. 
96. Harada N, Ishizawa T, Muraoka A et al. Fluorescence navigation hepatectomy by 
visualization of localized cholestasis from bile duct tumor infiltration. J Am Coll 
Surg. 2010;210:e2-6. 
97. Miyata A, Ishizawa T, Kamiya M et al. Photoacoustic tomography of human 
hepatic malignancies using intraoperative indocyanine green fluorescence imaging. 
PLoS One. 2014;9:e112667. 
98. van der Vorst JR, Schaafsma BE, Hutteman M et al. Near-infrared fluorescence-
guided resection of colorectal liver metastases. Cancer. 2013;119:3411-3418. 
99. Abo T, Nanashima A, Tobinaga S et al. Usefulness of intraoperative diagnosis of 
 30 
hepatic tumors located at the liver surface and hepatic segmental visualization using 
indocyanine green-photodynamic eye imaging. Eur J Surg Oncol. 2015;41:257-264. 
100. Barabino G, Porcheron J, Cottier M et al. Improving Surgical Resection of 
Metastatic Liver Tumors With Near-Infrared Optical-Guided Fluorescence 
Imaging. Surg Innov. 2016;23:354-359. 
101. Hiroshima Y, Lwin TM, Murakami T et al. Effective fluorescence-guided surgery 
of liver metastasis using a fluorescent anti-CEA antibody. J Surg Oncol. 
2016;114:951-958. 
102. Jo D, Hyun H. Structure-Inherent Targeting of Near-Infrared Fluorophores for 
Image-Guided Surgery. Chonnam Med J. 2017;53:95-102. 
103. Daly HC, Sampedro G, Bon C et al. BF2-azadipyrromethene NIR-emissive 
fluorophores with research and clinical potential. Eur J Med Chem. 2017;135:392-
400. 
104. Sun Y, Ding M, Zeng X et al. Novel bright-emission small-molecule NIR-II 
fluorophores for in vivo tumor imaging and image-guided surgery. Chem Sci. 
2017;8:3489-3493. 
105. Hill TK, Kelkar SS, Wojtynek NE et al. Near Infrared Fluorescent Nanoparticles 
Derived from Hyaluronic Acid Improve Tumor Contrast for Image-Guided Surgery. 
Theranostics. 2016;6:2314-2328. 
106. Burggraaf J, Kamerling IM, Gordon PB et al. Detection of colorectal polyps in 
humans using an intravenously administered fluorescent peptide targeted against c-
Met. Nat Med. 2015;21:955-961. 
107. Atreya R, Neumann H, Neufert C et al. In vivo imaging using fluorescent 
antibodies to tumor necrosis factor predicts therapeutic response in Crohn’s disease. 
Nat Med. 2014;20:313-318. 
108. Lee JH, Wang TD. Molecular endoscopy for targeted imaging in the digestive tract. 
Lancet Gastroenterol Hepatol. 2016;1:147-155. 
109. Liu J, Zuo X, Li C et al. In vivo molecular imaging of epidermal growth factor 
receptor in patients with colorectal neoplasia using confocal laser endomicroscopy. 
Cancer Lett. 2013;330:200-207. 
110. Mahmood U, Weissleder R. Near-infrared optical imaging of proteases in cancer. 
Mol Cancer Ther. 2003;2:489-496. 
111. Zhou J, Joshi BP, Duan X et al. EGFR Overexpressed in Colonic Neoplasia Can be 
Detected on Wide-Field Endoscopic Imaging. Clin Transl Gastroenterol. 
2015;6:e101. 
112. Joshi BP, Zhou J, Pant A et al. Design and Synthesis of Near-Infrared Peptide for in 
Vivo Molecular Imaging of HER2. Bioconjug Chem. 2016;27:481-494. 
113. Rabinsky EF, Joshi BP, Pant A et al. Overexpressed Claudin-1 Can Be Visualized 
Endoscopically in Colonic Adenomas In Vivo. Cell Mol Gastroenterol Hepatol. 
2016;2:222-237. 
114. Foersch S, Kiesslich R, Waldner MJ et al. Molecular imaging of VEGF in 
gastrointestinal cancer in vivo using confocal laser endomicroscopy. Gut. 
2010;59:1046-1055. 
 
 1 
Indocyanine Green Fluorescence Imaging in Colorectal Surgery: Reviewing the Current 
Literature, Applications, and Future Direction 
 
Deborah S Keller, MD, Department of Surgery, Baylor University Medical Center, 
Dallas, TX, USA; Department of Surgery, University College London Hospital, NHS 
Trust, London, UK 
 
Professor Takeaki Ishizawa, MD, Department of Gastroenterological Surgery, Cancer 
Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Japan 
 
Professor Richard Cohen, MD, Department of Surgery, University College London 
Hospital, NHS Trust, London, UK 
 
Manish Chand, PhD, Department of Surgery, University College London Hospital, NHS 
Trust, London, UK 
 
This paper has not been submitted to another journal, and has not been published in 
whole or in part elsewhere previously. 
Conflict of Interest: DK, TI, RC, and MC declared no conflicts of interest 
 
Address correspondence to: 
Manish Chand, MBBS MBA FRCS PhD 
Senior Lecturer and Consultant Surgeon 
Department of Surgery, University College London Hospital 
250 Euston Rd, Bloomsbury, London NW1 2BU 
Tel: 020 3447 5879 
Fax: 020 3447 9218 
manish.chand@uclh.nhs.uk  
 
 
 
 
  
*Manuscript
Click here to view linked References
 2 
ABSTRACT 
Indocyanine green (ICG) fluorescence imaging is a surgical tool with increasing 
applications in colorectal surgery. This tool has received acceptance in various surgical 
disciplines as a potential method to enhance surgical field visualization, improve lymph 
node retrieval, and decrease anastomotic leaks. In colorectal surgery specifically, small 
studies have shown intraoperative fluorescence imaging is a safe and feasible method to 
assess anastomotic perfusion, and its use may impact anastomotic leak rates. Controlled 
trials are underway to validate these conclusions. In the meantime, new indications for 
ICG continue to develop, including innovative options for detecting and guiding 
management of colorectal metastasis to the liver. These advances could offer great value 
for surgeons and patients, by improving the accuracy and outcomes of oncologic 
resections. The purpose of this article is to review the literature on the current state of 
immunofluorescence in colon and rectal surgery and emerging applications. 
 
KEY WORDS 
Immunofluorescence, indocyanine green (ICG); fluorescence angiography; fluorescence 
imaging; colorectal surgery; colorectal cancer 
 
  
 3 
Introduction to Fluorescence Imaging 
Fluorescence imaging (FI) is emerging as a major contributor to intraoperative decision 
making during surgical procedures. With FI, the tissue of interest is illuminated with light 
at an excitation wavelength (750 -800 nm) while observing it emit fluorescence at longer 
emission wavelengths (over 800 nm) (1). Indocyanine green (ICG) is the fluorophore 
most commonly used in fluorescence imaging. ICG is a water-soluble, tricarbocyanine 
dye that binds to blood lipoproteins after intravenous injection and remains confined in 
the intravascular compartment until elimination. It is selectively taken up at the first pass 
by hepatocytes and excreted unchanged into the bile. This fluorophore has tissue 
penetration up to 5mm, a plasma half-life of 3–5 min, with biliary excretion in 15–20 
min, making it ideal for repeated applications (2). ICG has been used in other clinical 
applications, such as determining cardiac output, hepatic function, liver blood flow, and 
ophthalmic angiography for several decades (1, 3, 4). Fluorescence imaging with the 
application of ICG is an area of new development, and the uses continue to grow in 
colorectal surgery. The long-standing safety and efficacy of ICG greatly facilitates its 
introduction to new applications in this field (1). To date, the most publicized application 
in colorectal surgery has been as fluorescence angiography for perfusion analysis of the 
colorectal anastomosis (5). However, the indications continue to expand, and these 
advances could offer great value for surgeons and patients, by improving the 
visualization, accuracy and outcomes of colorectal resections. The purpose of this article 
is to review the literature on the current state of immunofluorescence in colon and rectal 
surgery and emerging applications. 
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Search strategy and selection criteria 
For this narrative review, a team of surgeons that are subject matter experts in 
fluorescence angiography for gastrointestinal and hepatic surgery met to determine the 
clinically relevant areas and applications of fluorescence imaging with ICG in colorectal 
surgery. The consensus was: review of the available equipment, fluorescence 
angiography for anastomotic assessment, ureter visualization, endoscopic tattooing of 
colorectal lesions, lymphatic and sentinel lymph node mapping, and colorectal liver 
metastasis. Within each defined area, searches using the PubMed and Medline electronic 
databases were performed from database inception to May 2017 for original articles on 
the use if ICG in the setting of clinical studies in colorectal surgery. The following search 
terms were used: “fluorescence imaging”, “fluorescence angiography”, “Indocyanine 
green”, and “ICG” with “colorectal”, “colorectal surgery”, “perfusion”, “lymph node”, 
“sentinel lymph node”, “colorectal cancer”, “anastomotic leak”, “ureter” “hepatocellular 
cancer”, and “liver metastasis”, and “fluorophores” AND “imaging” AND “surgery”. 
Reference lists and specific authors who the team recognized as other subject matter 
experts in the field were also hand searched. Articles were included if published in 
English and full text was available. Conference proceedings and videos were not 
included. Abstracts were initially independently reviewed by 1 author (DK) for relevance 
to the defined sections and novelty. Then, full text for the selected articles was reviewed 
by all authors, minus the section on metastatic liver lesions, which was performed by TI. 
The content was written in a narrative format for full breadth of the details on the 
technical aspects, current state, and future application of the field. 
Fluorescence Angiography: The Technical Details 
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There are a few options for fluorescent angiography systems for laparoscopic and open 
surgery, including the Stryker 1588 AIM Platform (Portage, Michigan, USA), 
PINPOINT
TM 
(Novadaq, Mississauga, Ontario, Canada), the D-Light NIR/ICG
TM 
(Karl 
Storz, Tuttlingen, Germany), IC-View® (Pulsion Medical Systems, Munich, Germany), 
PDE-neo System
TM
 (Hamamatsu Photonics K.K., Hamamatsu, Japan), the SPY Elite™ 
Kit (LifeCell Corporation, Bridgewater, New Jersey, USA), and da Vinci robotic system- 
Firefly
TM
 (Intuitive Surgical Inc., Sunnyvale, California, USA). These systems function 
as a conventional laparoscope in white light mode, but can be activated into NIR mode, 
where the ICG is visualized as white fluorescence on a black background. The Novadaq 
system offers an additional PINPOINT dual display mode, where the green fluorescence 
is superimposed over the white-light image, providing a highlighted view of the tissue of 
interest (6). Surgeons should understand that the signal detectability in fluorescence 
imaging differs greatly among laparoscopic imaging systems and, in general, is inferior to 
open imaging systems (7). Studies have demonstrated the feasibility and safety of 
intraoperative fluorescence angiography using these systems, with no adverse effects 
related to the infusion of ICG (2, 5, 8–18). 
 
Fluorescence Angiography to Assess Anastomotic Perfusion 
Anastomotic leaks are a dreaded complication in gastrointestinal surgery. Despite 
technical advances in colorectal surgery, the rate of anastomotic leaks has been steady, 
reported in 3%-20% of colorectal cases (19, 20). The etiology of anastomotic leaks is 
multifactorial, and their impact is widespread- adding a significant clinical and economic 
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burden to the patient and healthcare system, as well as a predisposition to local cancer 
recurrence (20–26). The current diagnostic tests- including intraoperative endoscopic 
assessment, air leak testing, assessment of anastomotic donuts, measurement of local 
tissue oxygenation, CT scan, and water-soluble contrast enema- often fail to establish an 
anastomotic leak at stage early enough to allow timely intervention and minimize 
morbidity and mortality (24). And while a proximal diverting stoma can minimize the 
consequences of a leak, it does not reduce the risk (27). Thus, further study and new 
technology are warranted to address the issue of anastomotic leaks.   
 
Perfusion is vital for healing, and inadequate blood flow can result in failure of 
anastomotic healing and leak (28). Adequate perfusion of the anastomosis is commonly 
confirmed by assessing palpable pulses in the mesentery, lack of bowel discoloration, and 
pulsatile bleeding from its cut ends; however, this method of assessment can be 
subjective and difficult to quantify.  
 
A valuable tool to visualize perfusion of the bowel anastomosis is fluorescence 
angiography. Fluorescence angiography can help confirm anastomotic perfusion by 
visualizing the bowel perfusion intraoperatively in real-time. For detection of blood flow, 
2–3 mL of ICG solution (2.5 mg/mL) is injected intravenously during the operation by 
the anesthetist. After intravenous injection, ICG is visualized as green when excited by 
light in the near-infrared (NIR) spectrum with a NIR camera in 30-60 seconds (29). This 
assessment allows the surgeon to confirm or revise a proposed resection margin after 
 7 
ligation of the vascular pedicle and before the anastomosis is created (5, 8). This 
interrogation of perfusion before the anastomosis is especially relevant in non-anatomic 
resections, where aberrant or altered vascular anatomy can impair perfusion to the 
remaining colon (FIGURE 1). In addition, the surgeon can verify perfusion of the 
completed anastomosis with an endoscopic mucosal angiography evaluation of the join 
(9).  
 
There is a growing body of literature supporting intraoperative assessment of perfusion 
impacting intraoperative management and patient outcomes, including anastomotic leak 
rate in colorectal surgery. Many studies evaluating immunofluorescence in colorectal 
anastomosis are retrospective case series in both laparoscopic and robotic colorectal 
resections (2, 5, 8, 10–18). These studies describe the technique as simple, taking 
approximately 5 minutes to perform whether laparoscopic or robotic (2, 18), and 
providing useful intraoperative information about the vascular perfusion during 
minimally invasive colorectal surgery, with promise to reduce anastomotic leak rates. 
Boni et al reported results of 107 laparoscopic colorectal resections (40 right colectomies, 
10 splenic flexure segmental resections, 35 left colectomies, and 22 anterior resections), 
where fluorescence demonstrated an insufficiently perfused bowel margin in 4/107 
patients, which was revised before anastomosis; none of these patients had a clinical leak 
(10). Gröne et al reported outcomes for consecutive rectal cancer patients who underwent 
laparoscopic anterior and lower anterior resection with fluorescence angiography over a 
5-months period, finding perfusion imaging influenced surgical decision making in 28% 
of the patients; there was 1 anastomotic leak (6%, coloanal anastomosis) in all patients 
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during that period (11). Hellan et al. reported the outcome of perfusion assessment in 40 
patients having robotic left-sided colon or rectal resection, where angiography led to a 
change in the proposed transection line in 40% of cases; anastomotic leak occurred in 2 
patients whose site of transection had been revised (days 15 and 40) (18).  Jafari et al 
evaluated 16 robotic low anterior resections with ICG perfusion, where the use of 
fluorescence angiography resulted in revision of the proximal transection point before 
formation of the anastomosis in 19% of patients; only 1 anastomotic leak occurred in the 
fluorescence angiography group compared to 4 in a matched control group (8). Ris et al 
reported outcomes in 30 consecutive elective minimally invasive colorectal resections (24 
left-sided and 6 right-sided resections), where in addition to achieving no postoperative 
anastomotic leaks, the authors reported that visualizing the perfusion also encouraged 
avoidance of defunctioning stomas in three patients with low anastomoses (2). 
 
With increasing utilization of the tool, the quality and volume of the evidence for 
fluorescence angiography in anastomotic assessment continues to grow. Boni et al 
completed a case-matched study, comparing 42 fluorescent angiography patients to 38 
historic controls undergoing laparoscopic low anterior resection. From fluorescent 
angiography-demonstrated hypoperfusion, the planned anastomotic level was revised in 
4.7 %. There were 2 anastomotic leaks in the control group, and none in the fluorescent 
angiography group (30). While the sample size is too small to power conclusions, they 
felt it could lead to a reduction in the anastomotic leakage after total mesorectal 
excisions. Kudszus et al performed a case-matched study in 402 colorectal cancer 
patients, with a subgroup analysis by elective/ emergent case status and age, for the rate 
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of anastomotic revision for leakage. They found an overall reduction in the absolute 
revision rate of the anastomosis of 4% in with fluorescence angiography, with 
significantly reduced rate of revision in the subgroup analysis of patients undergoing 
elective resections (3.1% vs. 7.7%, p = 0.04, risk of revision reduced by 60%) and in 
patients older than 70 years (4.3% vs. 11.9%; p = 0.04, risk of revision reduced by 64%), 
supporting that ICG fluorescence may significantly reduce the rate of severe 
complications in colorectal surgery (31). Kin et al also performed a case-matched study 
in colectomy and proctectomy patient, but concluded that the technology was not 
associated with a reduced colorectal anastomotic leak (32). Five percent of patients in the 
fluorescent angiography group had a revision of the planned resection margin. In the 173 
pairs, they found 7.5% of the fluorescent angiography group developed an anastomotic 
leak versus 6.4% of controls. Multivariate analysis demonstrated that level of 
anastomosis and surgeon was associated with leaks (32). There were several issues with 
this study’s design that could account for the divergent results found in this work 
compared to other studies. The study was retrospective, with a historic control group used 
for matching. There was also a small overall sample size, and even smaller number of 
anastomotic leaks, (n=24), resulting in an underpowered analysis. With the lack of 
controlled studies and conflicting data, additional studies are necessary to determine 
whether this technology is beneficial for colorectal surgery. A recent systematic review 
of 10 cohort studies (916 patient) reported that intraoperative fluorescent angiography 
was associated with a reduced risk of anastomotic leakage (n = 23/693; 3.3 % (95 % CI 
1.97-4.63 %) compared with no fluorescent angiography assessment (n = 19/223; 8.5 %; 
95 % CI 4.8-12.2 %) (33).  In the PILLAR-II prospective, multicenter, open-label, 
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clinical trial performed at 11 centers across the United States, 139 patients undergoing 
left-sided colectomy and anterior resection had perfusion assessment (5). Fluorescence 
angiography changed the operative plan in 8% of patients (n=11). The overall 
anastomotic leak rate was 1.4%, and there were no anastomotic leaks in the 11 patients 
who had a change in operative plan. While the existing body of literature is promising, 
we await randomized data to define the role for fluorescence angiography in routine 
clinical practice. The PILLAR III multi-center randomized controlled trial is currently 
underway, and we anxiously await the results (ClinicalTrials.gov identifier: 
NCT02205307) (34). 
 
One limitation that deserves mention in the currently available NIR imaging systems is 
the subjective evaluation of fluorescence intensity and lack of quantitative data to 
measure tissue perfusion- leaving surgeons with the question, “How green is green?”  
Nerup et al aimed to establish a method to quantify perfusion in ICG fluorescence 
angiography in an animal model. After marking regions of interest in the stomach, the 
authors administered ICG and neutron-activated microspheres, performed NIR 
fluorescence, and then sampled the marked tissue to calculate the regional blood flow 
(35). They found a strong correlation between regional blood flow and the slope of the 
fluorescence curves, with acceptable correlation to predictive algorithms they developed. 
While the models show quantification of perfusion is feasible, the clinical applications of 
this theoretical work in animal models is pending (35). In 2 separate single-institution 
studies in human subjects, the absolute perfusion units were reported as a 
recommendation of when to resect; the threshold value for absolute perfusion units in 
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these reports were 18-20 (14, 36). Wada et al aimed to quantify assessment of intestinal 
perfusion by reviewing recorded video images and creating a time–fluorescence intensity 
curve at the point of bowel transection (37). They found that the fluorescence difference 
between maximum and baseline was the most indicative factor for anastomotic leak, with 
a sensitivity of 100% and a specificity of 92.5%. Further, no correlation between 
anastomotic leak and the time from ICG injection to the first visible fluorescence signal 
was found (37). While these studies are promising, controlled trials with larger sample 
sizes are needed to standardize and validate the quantitative models.  In the meantime, the 
adequacy of anastomotic perfusion remains subjective.  
 
 
Emerging Uses of Fluorescence Angiography in Colorectal Surgery  
While developed to assess perfusion, various other uses of fluorescence angiography are 
being reported, which compliment the standard of care in colorectal surgery, and could 
facilitate improving patient outcomes. 
Ureter Visualization 
Iatrogenic ureteral injury is a relatively rare but devastating complication in colorectal 
surgery, with significant morbidity (38, 39). While rare overall, a higher incidence is 
reported with laparoscopic colorectal surgery, especially in rectal cancer resections (40, 
41). Preoperative ureteral stenting is an option, but it has not been shown to decrease the 
risk of ureteral injury- only helping with early identification of ureteral injuries (42). In 
addition, there are complications and costs associated with placing stents, including 
increased operative time and an increase in length of stay (42, 43). ICG fluorescence of 
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the ureters has value for facilitating ureter identification, especially in minimally invasive 
colorectal surgery (FIGURE 2). The ICG binds proteins on urothelial layer on the ureter, 
reversibly staining the inner lining of the ureter, and allowing visualization of the green-
illuminated ureter under NIR fluorescence (44). As ICG fluorescence penetrates tissue, 
the intraureteral ICG may be used to localize the entire course of the ureters, even when 
obscured in fibrotic tissue. While the intraureteral ICG cannot detect thermal or 
devascularization injuries, full-thickness ureteral injuries can be identified cause readily 
apparent leakage of ICG into the surgical field (FIGURE 3). Studies have described the 
technique, feasibility, and utility for visual identification of the ureters during 
laparoscopic (45–47) and robotic surgery using the Firefly® system (44, 48–50). The 
protocols described between 0.125-1mg/kg of methylene blue (45, 47) and 10-25mg of 
ICG dissolved in 10-mL of sterile water and injected through the open catheter, either as 
a bolus or through slow infusion over 5 minutes (44, 48–50).  Maximum fluorescence 
was reported between 9 and 20 minutes from administration (45). The reported results 
describe bilateral ureters fluorescing green in 50-91% when methylene blue was used, 
and 100% of patients with ICG (44, 45, 47–50). The fluorescence persisted through the 
duration of the operative procedure (mean operative times 121- 171.3 minutes), despite 
some variation in brightness from the depth of the ureter to the peritoneal surface across 
patients (44, 48–50). No intraoperative or postoperative adverse effects attributable to 
fluorophore administration were reported (44, 47–49). Further study will determine the 
role for this useful adjunct to prevent iatrogenic ureteral injury during pelvic dissection in 
colorectal surgery. 
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Endoscopic Tattooing Of Colorectal Lesions 
Preoperative endoscopic tattooing of colorectal neoplasms facilitates localization at the 
time of surgery, and is crucial for appropriate resection and treatment planning (51). 
Tattooing has become especially important in the era of minimally invasive surgery, with 
the lack of tactile feedback afforded during resection (52). The correct measurement and 
appropriate margins facilitated by precise localization could directly impact recurrence 
and survival. India ink has been the standard marking agent, but complications have been 
reported, including perforation, peritonitis, abscesses, inflammatory pseudotumors, and 
adhesion-related ileus (53–55). ICG has been reported as the endoscopic tattoo agent in 
several studies to guide colorectal resections (56–61). In these reports, peritumoral 
injection before open or minimally invasive resection using NIR fluorescence to identify 
the lesion has been reported to be safe, feasible, and effective. No adverse effects have 
been reported and all colorectal lesions were visualized upon open or laparoscopic 
resection. The median time for injection of ICG has been reported as 4 days prior to 
resection, but the ICG has been described as visible up to 7 days after endoscopic 
injection; after 9-10 days, the agent was visible in only 20% of patients (58, 60). A 
comparative study was performed by Nagata et al, who endoscopically injected 24 
patients with both ICG and India ink injected at separate sites within 4 days of 
laparoscopic colorectal surgery (59). They found the NIR fluorescence showed tumor 
location clearly and accurately in 100% of patients, while 10 of 24 patients had negative 
staining of India ink. The site of ICG injection did not reveal fibrosis, inflammation, 
necrosis or microabscesses, while the India Ink injection sites had vasculitis, necrosis, 
edema, and neutrophilic infiltration of the bowel wall. While large scale, controlled trails 
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are needed to define the site, concentration, and timing, from the benefits reported, ICG 
has value as a preoperative marking agent to identify tumor location. 
Lymphatic Mapping and Sentinel Lymph Node Identification 
In oncologic resections, sentinel lymph node mapping allows targeted identification and 
harvesting of potentially metastatic lymph nodes (62). Taking a clue from breast and 
gynecologic malignancies (63, 64), ICG is emerging as a powerful tool for lymphatic 
mapping, identification of micrometastatic disease, and focused target nodal assessment 
in colorectal cancer. There is the potential that the NIR information could change the 
operative course and recommendations for adjuvant therapy postoperatively. A few 
studies have reported the ICG immunofluorescence provided valuable information for 
finding lymph nodes; if these nodes are present outside of the traditional resection field, 
the operative strategy could be changed from this information (61, 65–68). It was noted 
that ICG may be may be less reliable due to neoadjuvant therapy in rectal cancers (61). 
Near-infrared fluorescence mapping of the pelvic side-wall in low rectal cancer can also 
guide the need for extended lymphadenectomy in appropriate patients, and spare patients 
with tumor-negative sentinel nodes from the morbidity of a lateral pelvic sidewall node 
dissection (67, 69). Intraoperative lymphatic mapping may also help define the lymphatic 
course for tumors that have variable drainage or in reoperative cases, where lymphatic-
bearing tissue has been excised (56).  The sentinel lymph node biopsy could have specific 
utility in transanal resections of rectal cancer, where identification could change the 
treatment course to a more radical resection. Arezzo et al performed a submucosal ICG 
injection in 3 patients, then used NIR fluorescence to map the mesorectal lymphatics and 
guide full-thickness resection with any involved lymph nodes (70). In all 3 patients, the 
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pathologist confirmed presence of excised nodes, lack of metastasis, and the patients 
were spared radical surgery. Published studies have described the accuracy and benefit 
with this tool. Cahill et al used ICG with intraoperative fluorescence for real-time 
identification of the lymphatic drainage and sentinel mesocolic lymph nodes in 18 
patients undergoing laparoscopic surgery for colorectal cancer (56). They found the 
fluorescence helped identify the sentinel nodes- whether within the specimen or outside 
of the standard resection field- prior to formal dissection, and was valid to guide their 
resection. In their series, four of 18 patients had mesocolic sentinel lymph nodes outside 
of the traditional resection field identified with ICG immunofluorescence.  Hirche et al 
evaluated 26 patients with colon cancer with ICG, then visualized their lymphatic 
mapping and sentinel lymph nodes with immunofluorescence, comparing results to the 
histopathology for clinical feasibility, detection rate, and sensitivity (66). The found the 
ICG could have improved accuracy over conventional methods. Fluorescence imaging 
identified the sentinel lymph node in 25/ 26 patients (detection rate, 96%); metastatic 
involvement was found in 9/11 nodal positive patients by conventional histopathology, a 
sensitivity of 82% (66). To date, the rate of lymph node detection has been described 
from 89% to 98%, with a false negative rate of 18-67% (71). Nishigori et al reported in 
21 patients undergoing laparoscopic resection for colorectal cancer with intraoperative 
immunofluorescence, the lymph node mapping demonstrated 23.5% of patients required 
modifications in the extent of lymphadenectomy and 16.7 % required a change in the 
plan of the intestinal resection (68). A recent systematic review and meta-analysis review 
was performed to determine the overall sensitivity and specificity of ICG NIR 
fluorescence in sentinel lymph node detection in colorectal cancer. For 12 studies across 
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248 patients, the authors reported accuracy rate of 75.7% and pooled sensitivity and 
specificity rates of 71% and 84.6%, respectively (72). With further validation and 
accuracy, ICG immunofluorescence lymph node mapping could become a valuable tool 
to guide tailored, oncologic colorectal resections. However, further controlled trials are 
needed studies to determine the true impact and role on outcomes, especially in patients 
that have received neoadjuvant therapy. 
Detection of Colorectal Peritoneal Carcinomatosis  
In carcinomatosis with colorectal cancer, staging and the completeness of the 
cytoreductive surgery are important prognostic factors. (73) Fluorescence imaging may 
be a tool that facilitates intraoperative assessment of tumoral margins beyond the present 
methods of palpation and visual inspection (74). In a proof of concept study, Filippello et 
al showed ICG accumulation into the tumor mass of peritoneal carcinomatosis from 
colorectal cancer was due to the enhanced permeability and retention, which could be 
augmented with bevacizumab to inhibits neoangiogenesis (74). Barabino et al perfomed a 
pilot study of 10 patients to validate if ICG could to detect colorectal carcinomatosis in 
patients scheduled for cytoreductive surgery (73). After receiving 0.25 mg/kg of ICG 
intravenously 24 hours before surgery, 42/58 cancerous lesions were correctly identified 
(72.4%). However, 12/30 non-cancerous lesions were also identified, showing the test is 
sensitive but not specific. To improve the accuracy, Liberale et al looked at tumor-to-
background ratios in suspected lesions in patients with peritoneal metastases from 
colorectal cancer undergoing cytoreductive surgery. Patients received 0.25 mg/kg 
intravenous intraoperatively, then had a tumor-to-background ratio calculated for all 
resected lesions, finding a significant difference betweeb malignant and benign nodules. 
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In 29%, this information modified the surgical decision-making (75). While promising, 
further work is needed to improve the accuracy of this application. 
 
ICG to Guide Safe Transanal Total Mesorectal Excision (TaTME) 
A new procedure gaining popularity for TME dissection is to perform the procedure via a 
combined laparoscopic abdominal and transanal approach: transanal total mesorectal 
excision (TaTME) (76, 77). This new technique requires specific training and distinct 
pattern recognition from the abdominal approach (78). Consequently, there is potential to 
easily enter an incorrect plane, resulting in bleeding, autonomic nerve injury, and urethral 
injury – usually of the membranous portion from inadvertent mobilization of the prostate 
(79, 80). FI with ICG has been described to facilitate identifying the transanal TME 
dissection plane, which could potentially help avoid injuries, including to the urethra. 
Dapri et al demonstrated the intraluminal dissection plane NIR during a single TaTME 
case, helping to identify the presacral fascia and correct plane of dissection (81). In a 
cadaver proof of concept study, Barnes at al demonstrated the feasibility, with 
fluorescence to visualize the urethra specifically, demonstrating the urethra in eight of 
eight cadavers (82).  Further application of this tool and integration into TaTME training 
models could improve the safety and complication profile for this new procedure, 
especially during the learning curve. 
 
ICG to Confirm Traditional Anatomic Perfusion Models 
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ICG has also been used to verify blood flow (or lack thereof) in cases of ischemia, and to 
demonstrate the watershed areas and marginal arteries. Nowak et al used fluorescence 
angiography in 4 emergent cases of mesenteric ischemia, where recoverable, perfused 
regions of colon where visualized, and the length of bowel resected was significantly 
changed in 1 of the 4 cases (83). Watanabe et al used ICG to evaluate perfusion in 
patients who underwent left-sided and anterior resections with the blood flow through the 
last sigmoid arterial branch interrupted, leaving the rectosigmoid junction supplied by 
only the marginal artery (15). They found only 57.1% had a good anastomosis of the 
marginal artery near the rectosigmoid junction, with the remainder having either 
diminished, delayed or no fluorescence.  Ryu et al describe successful application of 
intraoperative ICG fluorescence angiography to confirm a reported watershed area in the 
Superior Rectal artery (84). With the new understanding of the mesentery as a continuous 
and contiguous structure with avascular areas between arterial trunks, this could provide 
useful information to guide precise anatomic resections (85, 86). In a single case, Atallah 
et al successfully used the technology for quantitative, real-time adequate perfusion 
assessment of an anorectal advancement flap (87). Future studies will no doubt expand on 
the use of fluorescence imaging to delineate anatomy and help guide appropriate 
resection. 
 
Metastatic Colorectal Lesions to the Liver 
ICG fluorescence imaging has been used in the field of hepatobiliary surgery for 
intraoperative identification of the bile ducts and hepatic tumors for years before its 
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application in colorectal perfusion assessment (88–90). ICG fluorescence imaging is 
emerging as a navigation tool for resecting metastatic hepatic tumors in laparoscopic 
hepatectomy. The tool may help surgeons safely and accurately identify colorectal 
metastatic lesions and complete laparoscopic hepatectomies, compensating for the 
limitations in tactile feedback and ultrasound intraoperative of the hepatic surfaces (91–
94). The accumulation of ICG in metastatic liver tumors is associated with biliary 
excretion disorders, which can be caused by morphological obstruction in the biliary 
system and/or functional decrease in biliary transport, and result in accumulation of ICG 
in the cancerous tissues after preoperative intravenous administration (95–98) (FIGURE 
4). While the tissue permeability of the fluorescence signal is limited to 5-8mm from the 
hepatic surfaces, the technique highly sensitive for detecting small and grossly 
unidentifiable metastatic lesions in real time, enhancing the accuracy of liver 
segmentation for resection and operative staging. (88, 99). The technical details regarding 
dose and timing of ICG administration have not yet been standardized for the 
intraoperative fluorescence imaging of metastatic hepatic tumors. In most cases, the ICG 
was administered for preoperative liver function test at a dose of 0.25-0.5 mg/kg body 
weight between 1 day and 2 weeks before surgery (91, 100). Since ICG-fluorescence 
imaging of hepatic tumors is not a cancer-specific modality, the false positive rates in the 
present technique are relatively high (~40%) (99). With this high false positive rate, 
lesions newly detected by ICG-fluorescence imaging should be confirmed by other 
modalities, such as palpation or intraoperative ultrasonography, before being resected. 
The false-positive rate can be reduced by not administering ICG on the day before 
surgery, especially in patients with decreased liver function from cirrhosis or preoperative 
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chemotherapy. With the development of cancer-specific fluorophores, the specificity of 
intraoperative fluorescence to identify colorectal cancerous tissues can be improved, and 
could potentially become standard of care (101). 
 
CONCLUSIONS 
ICG fluorescence imaging is a valuable tool that aids decision-making and potentially 
improves outcomes in colorectal surgery. While initially introduced as an agent to assess 
anastomotic perfusion, the applications of fluorescence angiography continue to evolve. 
The current literature demonstrates the tool is safe, feasible, and beneficial in a broad 
array of colorectal-related procedures. As we await prospective randomized controlled 
trials to define the standards for utilization, the tool continues to have a significant 
clinical benefit in minimally invasive colorectal surgery. Future studies will need to 
address the fluorophores used in fluorescence imaging. Currently, there are only two 
clinically available NIR fluorophores that support image-guided surgery: ICG (described 
here) and methylene blue. However, neither provides optimum specificity and stability 
for targeted image guidance (102). Therefore, it is of paramount importance to develop 
targeted NIR fluorophores for unmet clinical needs. New fluorophores are in 
development that are water soluble, biocompatible, have absorption and emission 
maxima within the desired NIR spectra, and improved fluorescence performance (103–
105). Novel agents are currently being tested in animal models, and some are used as 
molecular endoscopically tools, providing an enhanced, visual picture of the mucosal and 
molecular targets (106, 107). Fluorophores could also be used to label antibodies and 
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other biomarkers, repurposing a therapeutic agent into a diagnostic agent (108–114). 
Thus, developing fluorophores with the properties absent in the currently and may 
contribute towards the on-going expansion of NIR-fluorescence guidance in colorectal 
surgery. With this vast potential for expanded use, studies will need to define the cost-
effectiveness of fluorescence imaging in colorectal surgery. The cost of new technology 
can be prohibitive for resource-limited healthcare systems, limiting widespread 
application. While fluorescence imaging seems to have a cost benefit in reducing 
complications and guiding appropriate resections, studies on the true value, considering 
outcomes, costs, and the patient experience, are warranted.  
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FIGURE LEGEND 
Figure 1: Fluorescence Angiography to Assess Anastomotic Perfusion. Using ICG 
fluorescence angiography demonstrates a non-perfused segment in bowel that looked 
grossly healthy  
Figure 2: ICG infusion in the ureter  
Figure 3: ICG demonstrating a ureteral injury 
Figure 4: Identification of colorectal liver metastasis by ICG-fluorescence imaging during 
laparoscopic hepatectomy. a. Fluorescence imaging delineates small subcapsular hepatic 
metastasis located in segment 8 (right), which is unidentified by white-light color 
imaging (left) or intraoperative ultrasonography; b. Hepatic transection line is set using 
fusion-fluorescence imaging of the tumor, which enables superimposition of fluorescence 
signals on color images; c. The resected specimen is cut with the use of fluorescence 
imaging, and 3 mm-metastatic nodule appears on a cut surface of the specimen (left, 
arrow). The tumor shows rim-type fluorescence signals (right). 
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Reviewers' comments: 
 
Reviewer #1:  
 
Introduction 
1. The introduction essentially revolves around anastomotic leakage which gives an 
impression that the article is basically discussing this problem whereas the article is about 
ICG fluorescence and its uses in colorectal surgery which include, but not limited to, 
perfusion assessment. I propose to start the introduction with a background on ICG itself, 
its structure, development, uses in other medical fields then gradually proceed to discuss 
its primary indication in colorectal surgery highlighting anastomotic leakage in this 
context. 
Per the reviewer’s preference, the introduction and initial sections have been completely 
restructured, and these focused, additional details have been added into the text. 
 
2. First paragraph: "the current diagnostic tests often fail to…" it would be useful to 
enumerate these current diagnostic tests to the reader.  
Per the reviewer’s request, the details of intraoperative endoscopic assessment, air leak 
testing, assessment of anastomotic donuts, measurement of local tissue oxygenation, CT 
scan, and water-soluble contrast enema have been added into the text. 
 
3. Second paragraph: "Adequate perfusion of the anastomosis is commonly 
confirmed by the assessing palpable pulses in the mesentery", I assume it would read as 
"commonly confirmed by assessing palpable pulses in the mesentery" 
This has been corrected. 
 
Technical details 
4. Please clarify the meaning of the abbreviation "ICG" at the first appearance in the 
text as you did in the abstract. 
This has been expanded. 
 
5. Last sentence reads "Studies have demonstrated the feasibility and safety of 
intraoperative fluorescence angiography using these systems, with no adverse effects 
related to the infusion of ICG", however none of these studies were cited to support this 
sentence. 
Per the reviewer’s request, references were added here. 
 
Fluorescence Angiography to Assess Anastomotic Perfusion 
 
6. Page 7, line 4: the felt or they felt? 
This has been corrected. 
 
7. While all studies reported that ICG flouresence effectively managed to reduce 
anastomotic leakage; Kim et al (30) were the only authors who concluded that this 
technology was not associated with a reduced leak rate, is there something unique with 
this particular study regarding patients' characteristics, indications for or type of surgery 
*Reply to Reviewers Comments
performed that led to this contradiction? 
The article by Kin et al was divergent from the rest of the literature. There were several 
issues with this study’s design that could account for the divergent results found in this 
work compared to other studies. The study was retrospective, with a historic control 
group used for matching. There was also a small overall sample size, and even smaller 
number of anastomotic leaks, (n=24), resulting in an underpowered analysis. This has 
been added to the text. 
 
8. Since the PILLAR II trial is the only RCT included, it would be helpful to extend 
the discussion on its outcome. Also, the registered protocol of the PILLAR III trial could 
be cited as well in the text. 
PILLAR II was a prospective trial, but not RCT. Additional details of the PILLAR II 
outcomes are under the section for “Fluorescence Angiography to Assess Anastomotic 
Perfusion”. This has been highlighted for the reviewer’s easy review. PILLAR III is an 
RCT. The registered protocol for PILLAR III was added, as requested. 
 
9. The subjective assessment of flouresence intensity is indeed a shortcoming, a 
recent study employed quantitative assessment of flouresence angiography in animal 
model (N Nerup et al. Langenbecks Arch Surg 402 (4), 655-662) and concluded that 
quantitative assessment is not only feasible but also easy to perform, perhaps the authors 
may like to refer to this trial in their review. 
This animal model study has been added into the text as requested. 
 
Ureter Visualization 
10. Six studies evaluating the utility of ICG flouresence in the visual identification of 
the ureters during Laparoscopic or robotic colectomy were cited, however no mention of 
the outcome was made. Some information needs to be displayed such as: was the ureter 
clearly identified in all patients? Time elapsed between ICG injection and visualization of 
the ureter, and the incidence of ureteral injury in each study. 
Details for these studies have been added to the text. 
 
Lymphatic mapping and sentinel lymph node identification  
Some recent publications on the role of ICG flouresence in sentinel LN mapping could be 
added to this section as: 
 
11. A recent meta-analysis reported the median and pooled sensitivity and specificity 
rates of ICG flouresence in sentinel LN mapping in colorectal cancer (Emile SH et al, J 
Surg Oncol. 2017 Jun 1. doi: 10.1002/jso.24701), this meta-analysis emphasized the 
importance of standardizing the technique of ICG flouresence to achieve optimal 
outcomes. 
Per request, the reviewer’s work was included in the text. 
 
12. Watanabe and colleagues evaluated lymph flow pattern in splenic flexural cancers 
using ICG flouresence (Watanabe et al, Int J Colorectal Dis. 2017 Feb;32(2):201-207. 
doi: 10.1007/s00384-016-2669-4). 
ICG to Confirm Traditional Anatomic Perfusion Models 
This article is cited in the Anatomic model section 
 
13. I suggest to move this section to be included to the previous section discussing 
anastomotic perfusion since both sections reflect the same utility (perfusion assessment). 
We thank the author for his suggestion. This section details visualization of the ureters- 
not perfusion assessment, while the prior details anastomotic perfusion assessment.  
 
Primary and Metastatic Liver Lesions 
14. This section details the use of ICG flouresence in hepatic malignancies overall 
which is not really pertinent to the topic of the review. Since the review is all about the 
uses of ICG in colorectal surgery, a discussion of the utility of ICG-FI in detecting 
colorectal liver metastasis would be more appropriate and relevant whilst highlighting its 
mechanism referring to its original indication in primary hepatic malignancies. 
This section has seen revised and focused, as suggested. 
 
Additional comments 
15. Please add a section on other emerging clinical applications of ICG flouresence in 
colorectal surgery that were not discussed in this review such as: 
  1. Detection of colorectal peritoneal carcinomatosis (Flippelo et al, Surg Innov. 2017 
Apr;24(2):103-108. doi: 10.1177/1553350616681897), (Librale et al, Ann Surg. 2016 
Dec;264(6):1110-1115), (Barabino et al, Eur J Surg Oncol. 2016 Dec;42(12):1931-1937. 
doi: 10.1016/j.ejso.2016.06.389). 
  2. Application of ICG-FI in transanal TME to identify the plane of dissection (Dapri 
et al, Colorectal Dis. 2017 Jun;19(6):599-600. doi: 10.1111/codi.13698) and to highlight 
the urethra (Barnes et al, Tech Coloproctol. 2017 May 30. doi: 10.1007/s10151-017-
1615-y). 
  3. Assessment of perfusion of anodermal/anorectal advancement flap (Atallah et al, 
Dis Colon Rectum. 2013 Jun;56(6):797. doi: 10.1097/DCR.0b013e31828e1b71), (Turner 
et al, Dis Colon Rectum. 2016 Jul;59(7):700. doi: 10.1097/DCR.0000000000000640). 
  4. A revolutionary, yet still experimental, application of ICG-FI is in the assessment 
of anal blood supply in anorectal auto-transplantation (Araki et al, PLoS One. 
2012;7(9):e44310. doi: 10.1371/journal.pone.0044310) 
Per the reviewer’s comment, sections have been added or references incorporated into 
existing sections.  
 
16. One of the shortcomings of ICG-flouresence systems is their high cost that can be 
prohibitive for resource-limited communities, and hence limits its wide application. This 
should be discussed in the manuscript with emphasis on the cost-effectiveness of this 
technology as demonstrated in the literature.   
This limitation has been added to the conclusions. 
 
 
 
Reviewer #2: Although on page 4 of their manuscript the authors describe multiple 
commercially available systems for ICG imaging their illustrations focus strictly upon the 
equipment available by one manufacturer.  The only way that this manuscript would be 
suitable for publication is if the authors offered images from a variety of manufacturers to 
give a better balance.  For example, figures 1 and 2 do not lend any particular importance 
or help clarify comprehension of the subject, but seem almost like marketing for the 
Stryker company. 
Thank you for the suggestion- the company specific images were removed. 
 
[Editor's note: we agree, please remove the images of the specific systems from the 
manuscript] 
This was removed- thank you! 
 
Reviewer #3:  
 
1. Firstly, with reference to the originality of the study, it does not stand out from other 
reviews published so far on the same subject. The introduction and the description of the 
technical details are correct, but somewhat brief. Since it is a review of the literature, I 
believe that it would be appropriate to explain initially all the aspects that will be 
analyzed in the article, and not only the suture failure, which, although important, is not 
the only issue at hand, since other applications and their general use in colorectal surgery 
are also discussed. Introduction provide a background for the paper but don´t state the 
specific purpose (only named it in the abstract).  
This article synthesizes all current and emerging applications of ICG fluorescence in 
colorectal surgery imaging into a detailed narrative review, a unique addition to the 
literature to the best of our knowledge.  
The purpose was added to the introduction, with explanation that the review will describe 
popular current and emerging applications.  
 
2. Then it goes on to speak directly about the uses of the ICG without a section of 
material and methods. A section of material and methods should be presented, explaining 
how the literature review was carried out, which databases were used, what type of 
articles they analyzed and their number, as well as inclusion and exclusion 
criteria.  Reference to a minimum number of patients in the series collected, design of the 
studies analyzed, deadline for antiquity, literature only in English or not, etc. (Meta-
analyses, systematic reviews, review articles, randomised controlled trials and non-
randomised comparative studies including controlled clinical trials and cohort studies 
were included or not?). It would be useful also to know how the Quality Assessment of 
the included studies was performed.  
 
We thank the author for his suggestion. A “Search Strategy and Selection Criteria” was 
included at the end of the paper. This was a narrative review, not a systematic review or 
meta-analysis, where the included studies are graded, but the methods were detailed as 
requested. 
 
[Editor's note: this should be included as a Search Strategy and Selection Criteria panel at 
the end of the paper.] 
 
After explaining the context of the study, it goes on to explain one by one the uses of 
ICG,  
 
3. Fluorescence Angiography to Assess Anastomotic Perfusion 
In this section an adequate summary of the current situation of the use of ICG to asses 
anastomotic perfusion. The studies to which they refer are current and relevant. They also 
refer to future studies such as PILLAR III and also talk about new methods to evaluate 
the use of indocyanine green objectively and not subjectively as has been done so far. 
We thank the author for their comment that this section is adequate. There are no specific 
points to address. 
 
4. Emerging Uses of Fluorescence Angiography in Colorectal Surgery 
This section discusses the use of ICG in ureter visualization, endoscopic tattooing of 
colorectal lesions, lymphatic mapping and sentinel lymph node identification,  anatomic 
perfusion models and primary and metastatic liver lesions. The review of each topic is 
detailed, identifying in each case relevant literature on the subject, explaining sufficiently 
recent and innovative studies that support the objective to be addressed. 
Maybe in this section could have been added a reference to the use in the future  of 
fluorescent agents such as icg in what is believed to be  going to revolutionize the role of 
the fluorescence imaging system in oncologic surgery, the discovery of a contrast agent 
that binds to tumor-specific targets. To date, new fluorophores have been developed. 
They are characterized by improved fluorescent properties and can be conjugated to 
specific ligands. These contrast agents have already been tested in animals. The next step 
is to transfer the achieved results to human clinical trials. 
Discussion on the current and future state of fluorophores was added to the text. 
 
[Editor's note: we have published a review on molecular imaging in the digestive tract 
(http://www.thelancet.com/journals/langas/article/PIIS2468-1253(16)30027-9/fulltext) 
and a research article on molecular fluorescence guided surgery of peritoneal metastases 
of colorectal origin (http://www.thelancet.com/journals/langas/article/PIIS2468-
1253(16)30082-6/fulltext), which may be of use while researching this last component] 
Thank you for the provided references- they were used in the revision.  
 
5. The conclusions are short but clear, although they do not bring any novelty to highlight 
Additional text considering cost studies and the requested items on other fluorophores 
was added for novelty. 
 
 
Editorial comments: 
1. Please add a conflict of interest statement that matches the declarations on your 
author statement forms, which were submitted with your first draft. Authors should be 
referred to by their initials in this section. If there are none, then please state "The authors 
declared no conflicts of interest" or "The other authors declared no conflicts of interest". 
This has been added. The authors declare no conflicts of interest 
 
2. We require confirmation that the paper has not been submitted to another journal, and 
has not been published in whole or in part elsewhere previously. 
This paper has not been submitted to another journal, and has not been published in 
whole or in part elsewhere previously. A statement to this effect has been added to the 
cover page. 
 
 
3. Please check with your co-authors, and confirm, that all names are spelt correctly, and 
affiliations listed correctly. We cannot guarantee that we will be able to correct names 
and affiliations after publication of your article. 
This is correct, thank you 
 
4. Please provide: one preferred degree qualification per author and indicate any full 
professors; affiliation details (department, institute, city, state, country) for each author; 
full institutional correspondence address for corresponding author. 
This is completed 
 
5. Please supply the photographic figures as high-resolution TIF format. For more 
information, see download.thelancet.com/flatcontentassets/authors/artwork-
guidelines.pdf. 
 
The images have been reformatted per the guidelines. 
 
6. Please supply a section entitled "Search strategy and selection criteria". This should 
state clearly the sources (databases, journals, or book reference lists, etc) of the material 
covered and the criteria used to include or exclude studies. Please state which search 
terms, languages and date ranges were used. 
This has been added, thank you for allowing us to revise. 
 
--- End of editorial comments --- 
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